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PRESENTATION 
This work consists of two parts, with the aim to identify modifiable, lifestyle-
related risk factors, such as smoking and diet habits, of allergic rhinitis.  
Part one is a systematic review and meta-analysis on active and passive 
exposure to tobacco smoking and allergic rhinitis. The objective of this meta-
analysis was to examine the evidence for an association between active smoking 
and passive exposure to secondhand smoke and allergic rhinitis in children and 
adults. The results of this study were published in the international medical 
journal PLOS Medicine with an impact factor (2014) of 14.429, ranked 7th out of 
153 journals of general medicine. 
Part two of this work consists of a multicenter case-control study, which was 
carried out between January 2011 and October 2013. This study had the aim to 
shed light on modifiable dietary risk factors of allergic rhinitis. The main 
objectives of this study were to determine the effects of a high dietary intake of 
proteins, antioxidants and omega-3 and omega-6 polyunsaturated fatty acids on 
the occurrence of allergic rhinitis.  

ABBREVIATIONS AND ACRONYMS 
µg: Microgram 
ARIA: Allergic Rhinitis and its 
Impact on Asthma  
BMI: Body mass index  
CO: Carbon monoxide  
ECRH: The European Community 
Respiratory Health Survey 
FFQ: Food frequency questionnaire 
IFN-γ: Interferon gamma 
IgA: Immunoglobulin A 
IgE: Immunoglobulin-E  
IL-10: Interleukin-10 
IL-4: Interleukin-4 
IL-5: Interleukin-5 
ISAAC: The International Study of 
Asthma and Allergies in Childhood  
LT: Leukotriene 
n-3: Omega-3 
n-6: Omega-6 
NF-kB: nuclear factor kappa-light-
chain-enhancer of activated B cells 
NO2: Nitrogen dioxide 
NOx: Nitrogen oxide 
O3: Ozone  
PAR: Perennial allergic rhinitis  
PG: Prostaglandin 
PM: Particulate matter  
SAR: Seasonal allergic rhinitis 
SNP: Single nucleotide 
polymorphisms  
SO2: Sulphur dioxide  
SPSS: Statistical package for social 
sciences 
SPT: Skin prick tests 
STATA: Stata statistical software 
T cells: T lymphocytes 
Th1: Th1 helper cells 
Th2: Th2 helper cells 
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The inflammation of the nasal mucous membrane, mediated by 
immunoglobulin-E (IgE) production, is clinically called allergic rhinitis. 
Typically it is characterized by one or more of the following symptoms: nasal 
congestion, rhinorrhea, sneezing and itching of the nose which occurs after 
certain allergen exposure. Rhinitis is often linked to sinusitis because both block 
the sinuses causing an obstruction of the nose. As blocked sinuses are also a 
consequence of a number of other disabilities such as common cold, flu or nasal 
polyps, differential diagnosis of rhinitis may be difficult. According to specific 
allergens and seasonality allergic rhinitis may be seasonal or perennial. 
Classification of allergic rhinitis into intermittent and persistent was also 
adopted recently to describe duration and severity of symptoms.1 Recent data 
suggest that gene-environmental interactions are probably the most important 
risk factors for atopic diseases such as allergic rhinitis.2-4  
Allergic rhinitis is one of the most prevalent of all allergic disorders and has 
high direct and indirect cost as well as substantial impact on the quality of life, 
since it affects patients well-being and behavior and has serious impact on work 
and school performance. Over 600 million people suffer from allergic rhinitis 
worldwide and this number is constantly increasing, especially in developed 
and industrialized countries.5,6 Since this condition may be frequently 
trivialized (by the patient) and unrecognized (by the doctor), resulting in 
inadequate control of symptoms, this number probably underestimates the true 
magnitude of the disease which makes of it an important Public Health 
problem of this century.7
Allergy is classically considered to result from an IgE mediated reaction that 
causes inflammation. In the case of rhinitis, inflammation occurs in the nose 
lining and may be of variable intensity.1 In the allergic rhinitis disease, the 
process of allergen sensitization involves the participation of eosinophils, 
metachromatic cells, IgE-positive cells, macrophages and monocyte-like cells, 
which are redistributed towards the nasal epithelial surface due to exposure to 
allergens.8  Allergic reactions in allergic rhinitis occur in 2 phases according to 
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time sequence: one early phase 30 minutes after contact with allergens that 
causes sneezing and rhinorrhea, and one late phase, 6 hours after contact that 
produces nasal obstructions.9 
1.1. CLASSIFICATION  
According to the causes that induce rhinitis symptoms, this disease is divided 
in to three main groups: allergic rhinitis, non-allergic rhinitis and rhinitis of 
unknown factors. The ARIA Workshop Group in collaboration with WHO 
proposed a detailed classification, similar to that published by the International 
Rhinitis Management Working Group in 1994.1,10 The classification of rhinitis is 
shown on table1.   
Based on the type of allergen that causes the disease, the division of rhinitis into 
seasonal, perennial and occupational was used for a long time. When allergic 
rhinitis is caused by outdoor allergens, e.g. trees grass and weed pollens, it is 
often referred to as seasonal allergic rhinitis (SAR), or “hay fever”. Indoor 
allergens are usually present in perennial allergic rhinitis (PAR).10 These may 
include dust mites, molds, animal allergens, cockroaches or certain 
occupational allergens, as well as pollen in areas where pollen is prevalent 
perennially.  
In 2001 a new classification of allergic rhinitis was proposed by the ARIA 
Workshop Group and was updated in 2008.1,11 It recommended to replace the 
terms “seasonal” and “perennial” allergic rhinitis by “intermittent” and 
“persistent” according to the duration of the symptoms and included additional 
description of the severity of the disease. Intermittent allergic rhinitis is 
diagnosed when symptoms last for less than 4 days a week or less than 4 
consecutive weeks, while persistent allergic rhinitis is diagnosed when 
symptoms persist for more than 4 days/week and more than 4 consecutive 
weeks. Severity levels of “mild” and “moderate/severe” are used to measure 
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the effect of symptoms on sleep, work, and other activities. However, this new 
classification should be evaluated critically, because its validity is still 
unknown. Several studies confirm that there are no associations between the 
intermittent/persistent and the seasonal/perennial classifications and therefore 
these concepts cannot be used as alternative names for the same type of the 
disease.12-14 Finally, since this would not lead to a difference in treatment, the 
ARIA experts propose continuing to classify the severity of rhinitis as “mild” 
and “moderate/severe”.1 
Table 1. Classification of rhinitis1,10 
1 • Allergic 
     Intermittent (old term “seasonal”) 
     Persistent (old term “perennial”) 
2 • Infectious 
     Viral 
     Bacterial 
     Other infectious agents 
3 • Other 
Occupational (allergic and non-allergic) 
     Intermittent 
     Persistent 
Drug-induced 
Hormonal 
Idiopathic 
Other causes 
    NARES (non-allergic rhinitis with eosinophilia syndrome)
    Irritants 
    Food 
    Emotional 
    Atrophic 
    Gastroesophageal reflux 
Occupational allergic rhinitis develops in response to airborne substances in the 
workplace, such as grain, wood dusts or chemicals.15 Chronic nasal symptoms 
without allergic cause are the consequence of non-allergic rhinitis. One of the 
most common subtypes of non-allergic rhinitis is vasomotor rhinitis which is 
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defined as nasal symptoms which are not caused by an infection or allergy. The 
exact cause is unknown and symptoms are triggered by something that irritates 
the nose, such as temperature or barometric pressure changes, air pollution 
(including tobacco smoke), perfumes/fragrances, alcohol, medications, spicy 
foods or even strong emotions.15  
1.2. DIAGNOSIS 
The diagnosis of allergic rhinitis relies mostly on medical examination based on 
specific questions on existing symptoms, time of onset and duration. As allergic 
rhinitis is an IgE-mediated immune response against allergens, serum IgE 
concentration may be measured and skin prick tests (SPT) to common inhaled 
allergens performed.1 However the detailed assessment of symptoms, including 
their severity, is of utmost importance in the diagnosis. One should first 
determine whether the rhinitis is allergic or nonallergic and differentiate it from 
other conditions that have similar symptoms.  
According to criteria proposed by Allergic Rhinitis and its Impact on Asthma 
workshop directed by World Health Organization,1 patients with rhinitis have 
specific nasal symptoms which are rhinorrhea, nasal obstruction and nasal 
itching with sneezing. Other relevant symptoms may also be present: itching or 
watery eyes, postnasal drip, wheezing, chronic cough or headache. 
Typically, rhinitis is non-allergic when allergy has not confirmed by proper 
examination, such as history, SPT and measurement of serum specific IgE 
antibodies.1,16 However allergic rhinitis has some typical symptoms that helps 
differentiate it from the non-allergic form: nasal secretion is more watery and 
colorless, and symptoms usually are caused by specific allergens like house 
dust mites, pollen or animal dander. It is more often accompanied by ocular 
symptoms like itchy or watery eyes.10 Non-allergic rhinitis causes more 
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obstructive rhinorrhea and is triggered by factors such as humidity, tobacco 
smoke and changes in temperature.1,17 
After the diagnosis of allergic rhinitis has been confirmed, the differentiation of 
the subtype may be assessed according to the criteria mentioned above. 
Usually, perennial allergic rhinitis is identified when patients have frequent, 
non-seasonal, nasal or ocular symptoms. It often overlaps with sinusitis, 
respiratory infections, and vasomotor rhinitis.1,18 Seasonal allergic rhinitis is 
easy to identify because of the rapid and reproducible onset and offset of 
symptoms in association with pollen exposure. It is common that allergic and 
nonallergic rhinitis occur in the same patient and produce what is called 
“mixed rhinitis”.15  
Differential Diagnosis 
Allergic rhinitis is frequently associated with other allergic and non-allergic 
conditions, such as sinusitis, conjunctivitis, otitis media, sleep apnea, and 
fatigue.19-21 Sinusitis coexists in between 3.6% and 12.5% of allergic rhinitis 
patients.19,20,22 Poorly controlled allergic rhinitis may lead to the development of 
other nasal or sinus diseases, such as recurrent nasal polyps or acute and 
chronic sinusitis, ear disorders, such as otitis media, and hearing impairment; 
conditions caused by mouth breathing resulting from chronic nasal congestion, 
abnormal craniofacial development in children; sleep apnea and related 
complications.21,23-26 Two common medical conditions, otitis media and 
sinusitis, are often caused by obstruction of the Eustachian tube and sinus 
ostium due to allergic rhinitis. Patients with allergic rhinitis have significantly 
more respiratory and non-respiratory co-morbid conditions than patients 
without rhinitis.19-21 
Allergic rhinitis is also closely associated with other allergic conditions such as 
asthma, dermatitis and food allergies. Recent studies have suggested that these 
diseases are but one unique set of IgE-mediated allergic conditions, linked by 
the common thread of ‘‘atopic march’’.27 It was stated that this sequence usually 
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starts with allergic dermatitis during infancy and eventually progresses to food 
allergy, allergic rhinitis, and finally asthma (inflammation of the airways). 
These diseases often co-exist in the same patient and can predict the occurrence 
of each other.28 
1.3. BURDEN OF THE DISEASE 
Although allergic rhinitis is very frequent, the real incidence of this disorder 
remains unknown, while its prevalence ranges between 10 and 55% in 
Europe.29,30 The epidemiologic studies that assess the prevalence of this 
disorder often lack objective allergen skin testing data, most of them have small 
sample sizes and are based on questionnaire information only. In addition, self-
reported seasonal or perennial rhinitis symptoms significantly overestimate the 
prevalence of allergic rhinitis defined by a positive history and positive allergy 
tests. The various nonallergic causes of rhinitis may also lead to inaccurate 
prevalence estimates.  
Incidence 
Incidence data worldwide are scarce. Using nation-wide data of primary care 
institutions, an increase in the recorded incidence of allergic rhinitis was 
observed between 2001 and 2005 in England: the age-sex standardized 
incidence of allergic rhinitis was 5.57 per 1000 person-years in 2001 and 
increased by 33% to 7.41 per 1000 person-years in 2005.31 These figures are 
probably underestimated due to the fact that about 19% of patients with allergic 
rhinitis symptoms do not consult a general practitioner.32 Furthermore, non-
symptomatic cases with positive allergy tests are common. 
Prevalence 
Allergic rhinitis is an extremely common disease affecting 9.5–40.9% of the 
European population.29 Up to 47% of children and up to 55% of adults suffer 
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from this disorder worldwide.11,33-35 Most of allergic rhinitis patients suffer from 
perennial allergic rhinitis, although a large part of them present rhinitis of 
mixed etiology, involving sensitization to more than one trigger and 
manifestation of seasonal and perennial symptoms.7 Within the population 
with allergic rhinitis, about 40-55% of the cases are found to be perennial and 
11-49% seasonal, 4 to 40% of which have mixed etiology.13,18,19,36 
Authors have used both the seasonal/perennial and the intermittent/persistent 
classifications. Bauchau et al. used both classifications.13 Among allergic rhinitis 
patients 71% were found to be intermittent and 29% persistent. On the other 
hand, 49% of the cases were seasonal and 52% perennial.13
Some studies measure the prevalence of “allergic rhinitis symptoms ever” while 
other use the prevalence of current allergic rhinitis.37,38 The difference between 
the 2 measurements may be large: 9.4% vs. 41.6% for Graif et al. using different 
definitions of prevalence may lead to conflicting results for the same 
population.37 In addition, the fact that patients with perennial allergic rhinitis 
have more severe symptoms and higher self-awareness may lead to more 
frequent visits to a doctor.13,19,22  
The season of the year in which data are collected may influence the results 
since the incidence of seasonal allergic rhinitis symptoms can be significantly 
reduced out of the pollen season. The correct case assessment is one of the most 
complicated goals in studies in which there is no possibility either to carry out 
an interview of each participant or to obtain laboratory evidence of the immune 
response. Moreover, it was disclosed, that even when the diagnosis was based 
on skin prick test results there have been considerable differences in estimations 
of prevalence and incidence of atopy in populations, depending on the 
definition of skin prick test criterion used.1,11  
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Differences in the severity 
Two-third of allergic rhinitis patients suffer from moderate/severe symptoms 
of the disease.19,20,39 Bousquet et al. have examined 3000 allergic rhinitis 
patients, consulting general practitioners, and found that 93% of the cases we 
moderate-to-severe rhinitis and only 7% were mild.40 However, the Iberian 
Study of Aeroallergens Sensitization in Allergic Rhinitis revealed a higher 
prevalence of mild forms in intermittent allergic rhinitis in Spain and Portugal 
(82% and 92% respectively),14 although persistent types of rhinitis showed 
exactly the same proportion of severity in both countries, 44% mild and 56% 
moderate/severe. Usually, subjects with persistent allergic rhinitis have more 
severe symptoms and higher degree of self-awareness of this disease.13,19,22,41 
Differences in the prevalence around the world 
As mentioned before, the prevalence of symptoms related to allergic rhinitis 
varies widely all over the world. The lowest prevalence was reported in the less 
industrialized parts of the world. The European Community Respiratory 
Health Survey (ECRH) revealed that these symptoms are generally lower in the 
Mediterranean region (northern, central and southern Europe) and higher in 
the British Isles, New Zealand, Australia and the United States, with wide 
variations even within some countries.34,42 The Prevalence and Rate of Allergic 
rhinitis in Europe study (PAN-European) confirmed the same in 2001, reporting 
that allergic rhinitis has a higher prevalence in Western Europe.7 However the 
International Study of Asthma and Allergies in Childhood (ISAAC) revealed 
the lowest prevalence of rhinoconjunctivitis in parts of Eastern Europe, south 
and central Asia.43 The most common explanation of the fact that geographical 
pattern is consistent with the distribution of atopy is that these geographical 
variations most likely occur due to differences in environmental factors.42,43 
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Changes in the prevalence over the years  
One more reason that increases the concern of all researchers over the world is 
that the prevalence of allergic rhinitis is increasing, especially in developed and 
industrialized countries.6,7,31,43-45 According to the largest cross-sectional studies 
conducted in different years, the prevalence of allergic rhinitis was increasing 
steadily by 5% in the past and still continues to increase by 5%–20% in the past 
15 years.31,45-48 This increase is confirmed by many descriptive analyses dealing 
with various medical data bases, collected over the past decades.6,49,50 This 
increase concerns severe cases essentially. Mild cases were found to be 
decreasing.45,48 
1.4. IMPACT ON QUALITY OF LIFE AND ECONOMIC COST 
In addition to the characteristic nasal and ocular symptoms, patients may also 
experience fatigue, headache, disrupted sleep patterns and reduction in 
cognitive processing, psychomotor speed, verbal learning and memory.22 As a 
result, allergic rhinitis causes significant impairment on quality of life.22,51-53 
Most often health-related quality of life is correlated with disease severity and 
with the number of days in a defined period of time, in which the symptoms 
are absent.19,22 Two-thirds of patients with allergic rhinitis report impact from 
the symptoms on daily activities and more than half experience sleep 
disruption.19,20 Not only quality of life but cognition scores are significantly 
worse in subjects with allergic rhinitis compared to those without.52,54 The 
Burden of Rhinitis in America survey found that only 3.6% of subjects with 
allergic rhinitis symptoms experienced 100% sleep adequacy compared with 
11.7% of subjects with non-allergic rhinitis symptoms and 19.2% of subjects 
with no symptoms at all.52 Most often, this sleep inadequacy consists of factors, 
such as having trouble falling asleep, waking up several times at night and 
having trouble staying asleep.22 
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Poor night sleep has an impact on daily activities and work/school 
performance. About two thirds of allergic rhinitis patients report the negative 
influence of their symptoms on work/school performance and other daily 
activities.22,52,54-57 However, some data are contradictory. The Spanish 
“Alergológica-2005” study revealed that school performance was considered to 
be good in 79% of children with allergic rhinitis despite the fact that the large 
majority of them (87%) reported having at least one episode of allergic rhinitis 
in the previous year which caused absenteeism for several days.35 But still, 
health-related quality of life perceived by these patients was lower than that of 
the general Spanish population. 
In the US, it was estimated that in 1994 allergic rhinitis resulted in 
approximately 811.000 missed workdays, 824.000 missed school days, and 
4.230.000 days of reduced activity.58 These figures increased considerably and 
now they are as follows: 3.5 million lost workdays and 2 million lost schooldays 
annually.51 Worldwide, symptoms related to allergic rhinitis cause a total of 28 
million days of reduced function or productivity each year.56 Comorbid 
conditions such as asthma and sinusitis can be disabling as well, resulting each 
year in more than 10 million missed school days and more than 73 million days 
of restricted activity, respectively.59 In addition, all these effects lead not only to 
social harm, but also to substantial economic - direct, indirect, and hidden 
costs.51,60-62
Direct economic cost 
The economic impact of allergic rhinitis is high. Direct costs can be medical: 
such as the cost of medications, medical consultations, emergency room visits, 
diagnostic testing, home health-care devices, and hospitalizations.56 It was 
estimated that direct medical expenditures for the diagnosis and treatment of 
allergic rhinitis divides into the three main groups: outpatient services, which 
accounts for the majority of the expenditures (63%), medications (25%) and 
inpatient services (12%).63 Overall, about 14.1 million visits to a physician are 
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attributed to allergic rhinitis in the United States each year.64 The use of 
medication, especially of antihistamines, is increasing sharply over the 
world.20,31,35 The average annual cost of seasonal allergic rhinitis in Germany is 
€1089 per child/adolescent and €1543 per adult.65 
Almost all studies that estimate the economic burden of allergic rhinitis were 
conducted in the United States. In 1996, the estimated cost when 
rhinoconjunctivitis was the primary diagnosis was $1.9 billion. As a secondary 
diagnosis it was $4.0 billion, which gives a total of $5.9 billion for the overall 
direct medical expenditures.63 In 2002 the cost of allergic rhinoconjunctivitis as 
the primary diagnosis was estimated at $2.35 billion and as secondary diagnosis 
at $4.95 billion.66 Total expenditures were estimated at $7.3 billion ($4.58 billion 
for outpatient services, $1.86 billion for medications, and $0.87 billion for 
inpatient services).  
Indirect economic cost 
A significant number of lost workdays and lost schooldays annually, as well as 
side effects of treatment related to allergic rhinitis, lead to high indirect 
expenditures. Lost productivity can be assessed in terms of absenteeism from 
work and reduced working capacity, including caregiver absenteeism (absence 
from work to take care of a sick family member).67 There are very few studies 
designed to measure the indirect cost of allergic rhinitis, especially in Europe. In 
Sweden, the mean annual productivity loss for allergic rhinitis and common 
cold together was estimated at 5.1 days or €653 per worker, yielding a total 
productivity loss of €2.7 billion in this country.67  
Medicines that mitigate the symptoms of allergic rhinitis usually contain 
sedating antihistamines which are known to have central nervous system side 
effects such as somnolence and impaired learning, memory, and performance 
which increases the risk of acute injury.56,55,61,68 Indirect medical cost associated 
with traumatic injury in patients with allergic rhinitis was estimated at $143 
million in 2001 in the United States.61 
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It was disclosed that people with allergic rhinitis despite their nasal congestion, 
sneezing, rhinorrhea, and other symptoms, often do not seek medical advice, 
which leads to more severe health complications and increases the probability 
of using an inadequate medication. It was estimated that approximately 39 
million persons in the United States experienced allergic rhinitis. However, only 
12.3% (4.8 million) sought medical treatment for this condition.58 The fact that 
allergic rhinitis remains widely untreated or treated inadequately leads to a 
dramatic increase in the cost of treating comorbid conditions such as asthma, 
recurrent nasal polyps, sinusitis, and chronic otitis media.35,58,69,70 
In Europe, allergic rhinitis remains widely untreated and produces high 
economic cost. It was calculated that the decrease in lost productivity of 1 day 
per individual and year would potentially save approximately €528 million in 
each of the European countries.67  
1.5. RISK FACTORS 
According to ARIA Workshop Group, allergic rhinitis is a multi-factorial 
disease induced by gene-environment interactions.1 The most plausible cause of 
the increased prevalence over the last decades may be related to changes in the 
risk factors related to environment and lifestyle: diet, stress, pollution, 
immunizations and patterns of infection in childhood.11,71 The ‘hygiene 
hypothesis’ associated with the greatly improved sanitation, typical of a 
western lifestyle, is gaining credibility.11,71,72,73 The so called “hygiene 
hypothesis” states that early life exposures to infectious agents influence the 
development of the immune system in a manner that reduces a child’s 
likelihood of developing atopic diseases like allergic rhinitis and asthma later in 
life.73 
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1.5.1. Intrinsic factors 
Genetic factors  
Familial aggregation of cases of allergic rhinitis suggests that a common 
predisposing genetic factor might be involved in to the occurrence of this 
condition. The most important mechanism needed to trigger an episode of 
allergic rhinitis is the production of IgE. Through this mechanism important 
mediators such as cytokines and adhesion molecules are produced. Genes that 
encode total IgE response or functions of IgE receptors, as well as genes that 
mediate in the inflammation process are involved. They are essentially genes of 
interleukin (IL) (IL-4, IL-4R, IL-3, IL-28RA) or calcium-binding proteins such as 
S100A7. 
Recently, several single nucleotide polymorphisms (SNP) in different genes, 
such as S100A7, IL-28RA, and IL-18, were implicated in the occurrence of the 
disease.74-76 A locus in 11q13 is found to be important in the regulation of IgE,77 
and 14q11.2 is reported to be a susceptibility locus for allergic rhinitis and 
asthma.78 It should be emphasized that the role of the polymorphisms could be 
twofold. On the one hand, they could be an independent risk factor of allergic 
rhinitis. On the other hand, they could act as effect modifiers of other non-
genetic factors. 
Since allergic rhinitis, asthma and atopic dermatitis share common systemic 
characteristics, it is reasonable to consider that a number of susceptibility genes 
could contribute to the allergic process regardless of the specific clinical 
phenotype.  
Family history (Heredity) 
Probably the best established risk factor for allergic rhinitis is history of allergic 
rhinitis in family members.33,44,79,80 Compared with children whose parents are 
not atopic, children with one atopic parent develop allergies twice more often 
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and frequently at older age. Children with two atopic parents develop allergies 
almost four times more often and tend to be symptomatic already in 
childhood.81 Moreover, according to recent findings, a family history of rhinitis 
increases the risk for the comorbidity of rhinitis and asthma from 4 to more 
than 11 times.41,82 
Age and Gender 
As it was mentioned before, the history of atopic disease usually begins in 
infancy and early childhood with atopic dermatitis and food allergy and 
progresses to allergic rhinitis and/or allergic asthma later in life.10,70,83 A sharp 
increase in the lifetime prevalence of allergic rhinitis is observed in males and 
females during the first two decades of life (children and adolescents), with the 
highest prevalence at the age of 15–19 years.31,43,47,83 Thereafter, lifetime 
prevalence is observed to steadily decline in both sexes. In general, allergic 
rhinitis was found to be more common in the population whose age varies 
between 10 and 24 years.31,43 Analyzing the difference between types of rhinitis, 
some studies reveal that perennial allergic rhinitis is more common in adults 
than in children, while seasonal allergic rhinitis is more frequent in young 
population.80,84  
Differences between sexes are observed as well. Whilst lifetime prevalence of 
allergic rhinitis is higher in males before the teenage prevalence peak (children 
and adolescents),31,45,80,83,85 in the following years (young adults) female 
prevalence exceeds that of males.7,31,46,83,86 
Stress 
Stress occurs when individual perceive that environmental demands challenge 
an individual's adaptive capacity, or ability to cope.87 Typically psychological 
stress is associated with negative life events such as job loss, death of a loved 
one, family conflict and similar. It seems that psychological stress operates by 
altering the magnitude of the airway inflammatory response to environmental 
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triggers, allergens, and infections and, in doing so, increases the frequency, 
duration, and severity of patients' symptoms.88 This mechanism is also thought 
to be mediated by the effects of stress on neuro-immune regulation, which in 
turn modulates the hypersensitivity response. An indirect mechanism was also 
suggested, revealing that the relation between psychosocial factors and atopic 
disorders might be mediated via behavioral and socioeconomic pathways, such 
as stress induced changes in diet, smoking or other daily habits.89
In general, it was suggested that depression and anxiety have robust effects on 
the atopic disease, which indicates that psychosocial factors are involved in 
both the development and prognosis of atopic disorders.89 Individuals suffering 
recurrent depression were diagnosed to have allergic rhinitis three times more 
often than psychiatrically healthy controls.90 
Personality characteristics seem to play a role as well. Traits such as anxiety and 
stress vulnerability in situations characterized by failure, job overload or social 
conflicts were significantly higher in patients suffering from allergic rhinitis.91 It 
was found that anxiety enhances the effects of stress even in late phase allergic 
responses.4  
However, it is not clear yet whether stress is a cause of allergic rhinitis or a 
consequence of it. Does stressful lifestyle cause the development of allergy or, 
on the contrary, do allergy symptoms affect patient’s mental stability? Few 
studies proposed that hay fever by itself increases the risk of panic attack in 
patients.89,92 It was found that the effect of atopic disease on future mental 
health was stronger than that of psychosocial factors on the development and 
progression of atopic disease. 
Some studies found out that stress-relieving activities, such as listening to 
music, may decrease allergic responses in atopic individuals, whereas stress-
inducing activities, such as playing video games, had the opposite effect.93  
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1.5.2. Extrinsic factors 
Diet 
Lifestyle habits are the one that can be manipulated in order to prevent a 
disease. One of the most important components of lifestyle that has an influence 
on human’s health is nutrition. A general overview of recent data on the effect 
of macro and micronutrients on allergic rhinitis is displayed in table 2. We also 
included asthma in this overview, since these both conditions are closely related 
to each other and share many risk factors. The outcome “allergic diseases in 
general” was added to this review as many studies analyzed their data without 
differentiating the outcome, using atopy as a case definition. Results are not 
uniform in their conclusions. This may be due to different reasons: different age 
structure of the population, differences in data collection and study design, and 
above all, measurement error and misclassification, very frequent in nutritional 
studies. Moreover, most of the studies analyzing the impact of diet on allergic 
rhinitis did not correct for energy intake, due to the fact that diet questionnaires 
are usually incomplete and do not allow to calculate the total daily calorie 
intake. Also it is important to mention that the large majority of the studies 
focuses on children and high-risk families in which relatives are atopic of have 
antecedents of atopy. 
Ta
bl
e 
2.
  System
atic rev
iew of 
the imp
act of f
ood gro
ups an
d nutri
ents on
 the de
velopm
ent of a
llergic 
rhinitis
 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
M
ed
ite
rr
an
ea
n
di
et
 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
↓
 
Ch
at
zi 
L 
(2
00
7)
95
 
Cr
os
s s
ec
tio
na
l
7-
18
 y
ea
rs
↓
 
Ch
at
zi 
L 
(2
00
8)
96
 
Co
ho
rt
In
fa
nt
s u
p 
to
 6
.5
 y
ea
rs
Hi
gh
 M
ed
ite
rr
an
ea
n 
Di
et
 S
co
re
 d
ur
in
g 
pr
eg
na
nc
y 
↓
↓
de
 B
at
lle
 J 
(2
00
8)
97
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↓
↓
 
Ba
rr
os
 R
 (2
00
8)
98
 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↓
 
M
ar
co
s L
G 
(2
00
7)
99
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↓
 (n
ot
 si
gn
)
↓
 (n
ot
 si
gn
)
 
N
ag
el
 G
 (2
01
0)
10
0 
Cr
os
s s
ec
tio
na
l
8-
12
 c
hi
ld
re
n
↓
An
tio
xi
da
nt
s
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
Fr
ui
ts
, v
eg
et
ab
le
s
↓
M
ur
r C
 (2
00
5)
10
1 
Re
vi
ew
N
ot
 sp
ec
ifi
ed
 
"H
ea
lth
y 
fo
od
",
 re
d 
vi
ne
, g
re
en
 te
a
↑
↑
Ko
m
pa
ue
r J
 (2
00
6)
10
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
Ca
ro
te
no
id
s i
n 
bl
oo
d 
se
ru
m
↓
 
 
De
ve
re
ux
 (2
00
5)
10
3 
Re
vi
ew
↓
↓
 
Pi
ca
do
 (2
00
1)
10
4 
Ca
se
-c
on
tr
ol
Ad
ul
ts
no
Fr
ui
ts
 
Hu
an
g 
SL
 (2
00
1)
10
5 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
no
 
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
no
 
Ro
se
nl
un
d 
H 
(2
01
1)
10
6 
Cr
os
s s
ec
tio
na
l
0-
8 
in
fa
nt
s, 
ch
ild
re
n
↓
 
Ch
at
zi 
L 
(2
00
7)
95
 
Cr
os
s s
ec
tio
na
l
7-
18
 c
hi
ld
re
n,
 
te
en
ag
er
s 
Gr
ap
es
, o
ra
ng
es
, a
pp
le
s,
 to
m
at
oe
s
↓
 
Ba
rr
os
 R
 (2
00
8)
98
 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
↓
 
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
no
 
M
ar
co
s L
G 
(2
00
7)
99
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↓
 
Gu
tié
rr
ez
-D
el
ga
do
 R
I 
(2
00
9)
10
8
Cr
os
s s
ec
tio
na
l
6-
14
 c
hi
ld
re
n
↓
↓
Epidemiologic studies of the risk factors of allergic rhinitis 33
Jurgita Saulyte Introduction 
Ta
bl
e 
2.
 C
on
t.  
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
 
Fo
ra
st
ie
re
 F
 (2
00
0)
10
9  
Cr
os
s s
ec
tio
na
l 
6-
7 
ch
ild
re
n 
Ci
tr
us
 fr
ui
ts
, k
iw
i 
↓
 
↓
 
M
iy
ak
e 
(2
00
6)
10
9 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
 
no
 
Ro
se
nk
ra
nz
 R
R 
(2
01
2)
11
1
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↑
↑
Li
 J 
(2
01
2)
11
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↓
 
N
ag
el
 G
 (2
01
0)
11
3 
Cr
os
s s
ec
tio
na
l
8-
12
 c
hi
ld
re
n
↓
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ch
ild
re
n
no
Fi
be
r 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Ve
ge
ta
bl
es
Ro
se
nl
un
d 
H 
(2
01
1)
10
6 
Cr
os
s s
ec
tio
na
l
0-
8 
in
fa
nt
s, 
ch
ild
re
n
no
 
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
no
 
Gu
tié
rr
ez
-D
el
ga
do
 R
S 
(2
00
9)
10
8 
Cr
os
s s
ec
tio
na
l
6-
14
 c
hi
ld
re
n
↓
↓
 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
El
lw
oo
d 
P 
(2
00
1)
11
5 
Ec
ol
og
ic
al
13
-1
4 
ch
ild
re
n
↓
 
Ro
se
nk
ra
nz
  R
R 
(2
01
2)
11
1
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↑
↑
Li
 J 
(2
01
2)
11
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
Ra
w
 v
eg
et
ab
le
s 
↓
 
N
ag
el
 G
 (2
01
0)
11
3 
Cr
os
s s
ec
tio
na
l
8-
12
 c
hi
ld
re
n
Co
ok
ed
 g
re
en
 v
eg
et
ab
le
s
↓
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ch
ild
re
n
no
 
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
Vi
t. 
A 
Hu
an
g 
SL
 (2
00
1)
II1
17
 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s 
↓
 
Pi
ca
do
 (2
00
1)
10
4 
Ca
se
-c
on
tr
ol
Ad
ul
ts
no
Epidemiologic studies of the risk factors of allergic rhinitis 34 
Introduction Jurgita Saulyte
Ta
bl
e 
2.
 C
on
t. 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
Vi
t. 
E 
Hu
an
g 
SL
 (2
00
1)
II1
17
 
Cr
os
s s
ec
tio
na
l 
13
-1
7 
ye
ar
s 
↓
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Fo
ga
rt
y 
A 
(2
00
0)
11
8 
Cr
os
s s
ec
tio
na
l
18
-7
0 
ad
ul
ts
 
Vi
t.E
↓
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
Tr
oi
si 
(1
99
5)
11
9 
Co
ho
rt
Ad
ul
t w
om
en
↓
Be
ta
 c
ar
ot
en
e
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
 
↑
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↑
Ro
se
nl
un
d 
H 
(2
01
1)
10
6 
Cr
os
s s
ec
tio
na
l
8 
ye
ar
s c
hi
ld
re
n
↓
De
ve
re
ux
 (2
00
5)
10
3 
Re
vi
ew
↓
↓
Tr
oi
si 
(1
99
5)
11
9 
Co
ho
rt
Ad
ul
t w
om
en
↓
 (n
ot
 si
gn
)
Vi
t. 
C 
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
no
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Ko
m
pa
ue
r I
 (2
00
6)
10
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
Vi
t.C
 in
 se
ru
m
 
no
De
ve
re
ux
 (2
00
5)
10
3 
Re
vi
ew
↓
↓
Vi
t. 
D 
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
no
Ch
en
g 
HM
 (2
01
3)
12
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
Vi
t.D
 in
 se
ru
m
  
no
Ar
sh
i S
 (2
01
2)
12
1 
Ca
se
-c
on
tr
ol
Ad
ul
ts
 
Vi
t.D
 in
 se
ru
m
  
↑
Bä
ck
 O
 (2
00
9)
12
2 
Co
ho
rt
6 
ye
ar
s c
hi
ld
re
n 
Vi
t.D
 su
pp
le
m
en
ts
 in
 in
fa
nc
y
↑
W
jst
 M
 (2
00
9)
12
3 
Re
vi
ew
Vi
t.D
 su
pp
le
m
en
ts
↑
M
ai
 X
M
 (2
01
4)
12
4 
Co
ho
rt
Ad
ul
t m
en
Se
ru
m
 2
5-
hy
dr
ox
yv
ita
m
in
 D
↑
M
ai
 X
M
 (2
01
4)
12
4 
Co
ho
rt
Ad
ul
t w
om
en
Se
ru
m
 2
5-
hy
dr
ox
yv
ita
m
in
 D
↓
Epidemiologic studies of the risk factors of allergic rhinitis 35
Jurgita Saulyte Introduction 
Ta
bl
e 
2.
 C
on
t.  
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
Fo
la
te
 
O
ku
pa
 A
Y 
(2
01
3)
12
5 
Co
ho
rt
 
8 
ye
ar
s c
hi
ld
re
n 
Fo
la
te
 le
ve
ls 
in
 b
lo
od
 sa
m
pl
e 
no
 
↑
 
Ca
 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↓
M
g 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↓
 (n
ot
 si
gn
)
Ro
se
nl
un
d 
H 
(2
01
2)
12
6  
Cr
os
s s
ec
tio
na
l
8 
ye
ar
 c
hi
ld
re
n
↓
Hi
ja
zi
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
P 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↓
Zn
 
M
iy
ak
e 
(2
00
6)
11
0 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
K 
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
N
a 
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
Pr
ot
ei
ns
 
El
lw
oo
d 
P 
(2
00
1)
11
5 
Ec
ol
og
ic
al
(c
ro
ss
 se
ct
io
na
l) 
13
-1
4 
ye
ar
s
Pr
ot
ei
ns
 fr
om
 c
er
ea
l, 
nu
ts
, s
ta
rc
h,
 
ve
ge
ta
bl
es
 
↓
Da
iry
 p
ro
du
ct
s
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
↓
↓
Hu
an
g 
SL
 (2
00
1)
10
5 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
M
ilk
↑
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
M
ilk
↑
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
Bu
tt
er
↓
Gu
tié
rr
ez
-D
el
ga
do
 R
I 
(2
00
9)
10
8
Cr
os
ss
ec
tio
na
l
6-
14
 c
hi
ld
re
n
no
 
Ro
se
nk
ra
nz
  R
R 
(2
01
2)
11
1
Cr
os
s s
ec
tio
na
l
Ad
ul
t m
en
Ch
ee
se
↑
↑
Ad
ul
t w
om
en
Ch
ee
se
↓
↓
Pe
rk
in
 M
R 
(2
00
6)
12
8 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n 
M
ilk
 (u
np
as
te
ur
ize
d)
↓
Ta
m
ay
 Z
 (2
01
3)
12
9 
Cr
os
s s
ec
tio
na
l
13
-1
4 
ch
ild
re
n
Bu
tt
er
↑
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ch
ild
re
n
Fa
t m
ilk
, b
ut
te
r 
↓
Du
nd
er
 T
 (2
00
1)
13
0 
Co
ho
rt
Ch
ild
re
n
Bu
tt
er
↓
 
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↓
Epidemiologic studies of the risk factors of allergic rhinitis 36 
Introduction Jurgita Saulyte
Ta
bl
e 
2.
 C
on
t.
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
N
w
ar
u 
BI
 (2
01
2)
13
1 
Co
ho
rt
 
In
fa
nt
s u
p 
to
 5
 y
ea
rs
 
M
at
er
na
l c
on
su
m
pt
io
n 
du
rin
g 
pr
eg
na
nc
y 
 
↑
Ki
m
 JL
 (2
00
5)
13
2 
Cr
os
s s
ec
tio
na
l
5-
14
 c
hi
ld
re
n
M
ilk
 (f
re
sh
) 
↓
Fi
sh
 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
Fi
sh
 fa
t
↓
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
no
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↓
 (n
ot
 si
gn
)
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
no
M
ar
co
s L
G 
(2
00
7)
99
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
Se
a 
fo
od
 
↓
↓
Gu
tié
rr
ez
-D
el
ga
do
 R
I 
(2
00
9)
10
8 
Cr
os
s s
ec
tio
na
l
6-
14
 c
hi
ld
re
n
no
 
Kr
em
m
yd
a 
LS
 (2
01
1)
13
3 
Re
vi
ew
In
fa
nt
s a
nd
 c
hi
ld
re
n
Fi
sh
, f
ish
 o
il 
su
pp
le
m
en
ta
tio
n
↓
Vi
rt
an
en
 S
M
 (2
01
0)
13
4 
Co
ho
rt
In
fa
nt
s u
p 
to
 5
 y
ea
rs
↓
Ro
se
nk
ra
nz
  R
R 
(2
01
2)
11
1 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
Se
af
oo
d 
↑
↑
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Li
 J 
(2
01
2)
11
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↓
N
ag
el
 G
 (2
01
0)
11
3 
Cr
os
s s
ec
tio
na
l
8-
12
 c
hi
ld
re
n
↓
Sc
hn
ap
pi
ng
er
 M
 
(2
00
9)
13
6 
Ca
se
-c
on
tr
ol
Ad
ul
ts
↓
Ta
m
ay
 Z
 (2
01
3)
12
9 
Cr
os
s s
ec
tio
na
l
13
-1
4 
ch
ild
re
n
Fi
sh
 a
nd
 se
af
oo
d
↑
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ch
ild
re
n
no
M
ol
in
as
 JL
 (2
01
0)
13
7 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
Se
a 
fis
h 
↓
↓
N
af
st
an
d 
P 
(2
00
3)
13
8 
Co
ho
rt
4 
ye
ar
s c
hi
ld
re
n
Fi
sh
↓
↓
An
dr
ea
sy
an
 K
 (2
00
5)
13
9 
Co
ho
rt
8 
ye
ar
s c
hi
ld
re
n
Fi
sh
↓
↓
↓
Epidemiologic studies of the risk factors of allergic rhinitis 37
Jurgita Saulyte Introduction 
T
ab
le
 2
. C
on
t. 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
Ku
ll 
I (
20
06
)14
0 
Co
ho
rt
 
4 
ye
ar
s c
hi
ld
re
n 
Fi
sh
 
↓
 
↓
 
Ta
ke
m
ur
a 
Y 
(2
00
2)
14
1 
Ca
se
-c
on
tr
ol
6-
15
 c
hi
ld
re
n
Fi
sh
↑
Ki
m
 JL
 (2
00
5)
13
2 
Cr
os
s s
ec
tio
na
l
5-
14
 c
hi
ld
re
n
Fi
sh
↓
M
ag
nu
ss
on
 J 
(2
01
5)
14
2 
Co
ho
rt
8 
to
 1
6 
ye
ar
s c
hi
ld
re
n
O
ily
 fi
sh
↓
 
Du
nd
er
 T
 (2
00
1)
13
0 
Co
ho
rt
Ch
ild
re
n
Fi
sh
no
no
no
O
m
eg
a-
3 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
Fi
sh
 fa
t
↓
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
EP
A 
(C
20
:5
)
↓
Ho
ff 
S 
(2
00
5)
14
3 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↓
M
iy
ak
e 
Y 
(2
01
1)
14
4 
Cr
os
s s
ec
tio
na
l
6-
15
 y
ea
rs
Ar
ac
hi
do
ni
c 
(C
20
:4
)
no
W
ak
ai
 K
 (2
00
1)
14
5 
Cr
os
s s
ec
tio
na
l
22
-5
7 
ad
ul
t w
om
en
no
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
C2
0:
5 
&
 C
22
:6
 
no
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Sc
hn
ap
pi
ng
er
 M
 
(2
00
9)
13
6
Ca
se
-c
on
tr
ol
Ad
ul
ts
C2
2:
6 
DH
A 
↓
An
an
da
n 
C 
(2
00
9)
14
6 
Re
vi
ew
 a
nd
 
M
et
a-
An
al
ys
is 
 
Ad
ul
ts
no
no
Yu
 G
 (1
99
8)
14
7 
Ca
se
-c
on
tr
ol
Ad
ol
es
ce
nt
s 
C2
0:
5 
in
 b
lo
od
 se
ru
m
↑
Lo
w
e 
AJ
 (2
00
8)
14
8 
Co
ho
rt
In
fa
nt
s 
w
3 
co
nc
en
tr
at
io
n 
in
 b
re
as
t m
ilk
no
no
N
w
ar
u 
BI
 (2
01
2)
13
1 
Co
ho
rt
In
fa
nt
s u
p 
to
 5
 y
ea
rs
C1
8:
3 
an
d 
to
ta
l P
U
FA
 m
at
er
na
l 
co
ns
um
pt
io
n 
du
rin
g 
pr
eg
na
nc
y 
↓
Al
m
qv
ist
 C
 (2
00
7)
14
9 
Co
ho
rt
5 
ye
ar
 c
hi
ld
re
n
w
3 
pl
as
m
a 
le
ve
ls
no
no
 
Kr
em
m
yd
a 
L-
S 
(2
01
1)
13
3 
Re
vi
ew
In
fa
nt
s a
nd
 c
hi
ld
re
n
Fi
sh
, f
ish
 o
il 
su
pp
le
m
en
ta
tio
n
↓
M
ag
nu
ss
on
 J 
(2
01
5)
14
2 
Co
ho
rt
8 
to
 1
6 
ye
ar
s c
hi
ld
re
n
↓
Epidemiologic studies of the risk factors of allergic rhinitis 38 
Introduction Jurgita Saulyte
Ta
bl
e 
2.
 C
on
t. 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
 
Du
nd
er
 T
 (2
00
1)
13
0 
Co
ho
rt
 
Ch
ild
re
n 
Se
ru
m
 E
PA
 (C
20
:5
) &
 D
HA
 (C
22
:6
) 
↓
 
O
m
eg
a-
6 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
↑
 
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
 
Li
no
le
ic
 a
ci
d 
(C
18
:2
)
↓
Ho
ff 
S 
(2
00
5)
14
3 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
no
Ch
at
zi 
L 
(2
00
7)
95
 
Cr
os
s s
ec
tio
na
l
7-
18
 y
ea
rs
M
ar
ga
rin
e 
(w
6)
 
↑
M
iy
ak
e 
Y 
(2
01
1)
14
4 
Cr
os
s s
ec
tio
na
l
6-
15
 y
ea
rs
Ar
ac
hi
do
ni
c 
(C
20
:4
)
↓
Tr
ak
-F
el
le
rm
ei
er
 M
A 
(2
00
4)
15
0
Cr
os
s s
ec
tio
na
l
20
-6
4 
ad
ul
t m
en
M
ar
ga
rin
e 
 (w
6)
↑
Bo
lte
 G
 (2
00
5)
15
1 
Cr
os
s s
ec
tio
na
l
18
-2
9 
yo
un
g 
ad
ul
ts
M
ar
ga
rin
e 
 (w
6)
no
↑
W
ak
ai
 K
 (2
00
1)
14
5 
Cr
os
s s
ec
tio
na
l
22
-5
7 
ad
ul
t w
om
en
↑
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
Bo
lte
 G
 (2
00
1)
15
2 
Cr
os
s s
ec
tio
na
l
5-
14
 c
hi
ld
re
n
M
ar
ga
rin
e 
(w
6)
 
↑
Ko
m
pa
ue
r I
 (2
00
5)
15
3 
Cr
os
s s
ec
tio
na
l
20
-6
4 
ad
ul
ts
Ar
ac
hn
oi
di
c 
(C
20
:4
) a
ci
d 
in
 se
ru
m
↑
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
An
an
da
n 
C 
(2
00
9)
14
6
Re
vi
ew
 a
nd
 
M
et
a-
An
al
ys
is 
 
Ad
ul
ts
no
no
Yu
 G
 (1
99
8)
14
7 
Ca
se
 c
on
tr
ol
Ad
ol
es
ce
nt
s
w
6 
(C
20
:2
) i
n 
se
ru
m
↑
Lo
w
e 
AJ
 (2
00
8)
14
8 
Co
ho
rt
In
fa
nt
s 
w
6 
co
nc
en
tr
at
io
n 
in
 c
ol
os
tr
um
↑
no
Al
m
qv
ist
 C
 (2
00
7)
14
9 
Co
ho
rt
5 
ye
ar
 c
hi
ld
re
n
w
6 
pl
as
m
a 
le
ve
ls
no
no
O
m
eg
a-
6 
/ 
O
m
eg
a-
3 
ra
tio
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
Hi
gh
 w
6/
w
3 
ra
tio
 (m
or
e 
w
6)
↓
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
 
Hi
gh
 w
6/
w
3 
ra
tio
  (
m
or
e 
w
6)
↓
Tr
ak
-F
el
le
rm
ei
er
 M
A 
(2
00
4)
15
0
Cr
os
s s
ec
tio
na
l
20
-6
4 
ad
ul
t m
en
Hi
gh
 w
6/
w
3 
ra
tio
  (
m
or
e 
w
6)
↑
Epidemiologic studies of the risk factors of allergic rhinitis 39
Jurgita Saulyte Introduction 
Ta
bl
e 
2.
 C
on
t.  
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l 
Ad
ul
t w
om
en
 
no
 
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
N
w
ar
u 
BI
 (2
01
2)
13
1
Co
ho
rt
In
fa
nt
s u
p 
to
 5
 y
ea
rs
M
at
er
na
l c
on
su
m
pt
io
n 
du
rin
g 
pr
eg
na
nc
y 
 
↑
 
O
dd
y 
W
H 
(2
00
4)
15
4 
Co
ho
rt
6-
8 
ch
ild
re
n
Lo
w
 w
6/
w
3 
(m
or
e 
w
3)
↓
O
m
eg
a-
9 
(M
U
FA
) 
N
ag
el
 G
 (2
00
3)
10
0 
Co
ho
rt
Ad
ul
ts
O
le
ic
 a
ci
d 
(C
18
:1
)
↑
Ho
ff 
S 
(2
00
5)
14
3 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
no
Tr
ak
-F
el
le
rm
ei
er
 M
A 
(2
00
4)
15
0
Cr
os
s s
ec
tio
na
l
20
-6
4 
ad
ul
ts
O
le
ic
 a
ci
d 
(C
18
:1
)
↑
W
ak
ai
 K
 (2
00
1)
14
5 
Cr
os
s s
ec
tio
na
l
22
-5
7 
ad
ul
t w
om
en
no
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
Fi
sh
 o
il 
Ta
m
ay
 Z
 (2
01
3)
12
9 
Cr
os
s s
ec
tio
na
l
13
-1
4 
ch
ild
re
n
↓
Ca
ld
er
 P
C 
(2
01
0)
15
5 
Re
vi
ew
In
fa
nt
s 
Fi
sh
 o
il 
su
pp
le
m
en
ta
tio
n
↓
Kr
em
m
yd
a 
LS
 (2
01
1)
13
3 
Re
vi
ew
In
fa
nt
s a
nd
 c
hi
ld
re
n
Fi
sh
, f
ish
 o
il 
su
pp
le
m
en
ta
tio
n
↓
 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
Fi
sh
 fa
t
↓
Fa
ts
 (t
ot
al
)
Hu
an
g 
SL
 (2
00
1)
11
7  I
I 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
no
↑
Ch
at
zi 
L 
(2
00
7)
95
 
Cr
os
s s
ec
tio
na
l
7-
18
 y
ea
rs
M
ar
ga
rin
e 
↑
de
 B
at
lle
 J 
(2
00
8)
97
 
Cr
os
s s
ec
tio
na
l
6-
7 
ye
ar
 c
hi
ld
re
n
↑
Epidemiologic studies of the risk factors of allergic rhinitis 40 
Introduction Jurgita Saulyte
Ta
bl
e 
2.
 C
on
t. 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
 
Tr
ak
-F
el
le
rm
ei
er
 M
A 
(2
00
4)
15
0
Cr
os
s s
ec
tio
na
l 
20
-6
4 
ad
ul
t m
en
 
M
ar
ga
rin
e 
↑
Bo
lte
 G
 (2
00
5)
15
1 
Cr
os
s s
ec
tio
na
l
18
-2
9 
yo
un
g 
ad
ul
ts
M
ar
ga
rin
e 
no
↑
Bo
lte
 G
 (2
00
1)
15
2 
Cr
os
s s
ec
tio
na
l
5-
14
 c
hi
ld
re
n
M
ar
ga
rin
e 
↑
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
 
no
 
Ta
m
ay
 Z
 (2
01
3)
12
9
Cr
os
s s
ec
tio
na
l
13
-1
4 
ye
ar
s
An
im
al
 fa
ts
 
↑
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ye
ar
s
M
ar
ga
rin
e 
no
W
ei
la
nd
 S
K 
(1
99
9)
15
6 
Ec
ol
og
ic
al
 (I
SA
AC
)
13
-1
4 
ye
ar
s
Tr
an
s f
at
ty
 a
ci
ds
 (d
ai
ry
pr
od
uc
ts
, f
at
 o
f r
um
in
an
t a
ni
m
al
s,
 a
nd
 
in
du
st
ria
lly
 h
yd
ro
ge
na
te
d 
ve
ge
ta
bl
e 
fa
ts
 
su
ch
 a
s m
ar
ga
rin
e)
 
↑
↑
 
Du
nd
er
 T
 (2
00
1)
13
0 
Co
ho
rt
Ch
ild
re
n
M
ar
ga
rin
e 
↑
N
w
ar
u 
BI
 (2
01
2)
13
1 
Co
ho
rt
In
fa
nt
s u
p 
to
 5
 y
ea
rs
Bu
tt
er
. M
at
er
na
l c
on
su
m
pt
io
n 
du
rin
g 
pr
eg
na
nc
y 
  
↑
Fa
st
 fo
od
 
Sa
ad
eh
 D
 (2
01
3)
94
 
Re
vi
ew
0-
18
 y
ea
rs
↑
Hu
an
g 
SL
 (2
00
1)
10
5 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
De
ep
 fr
ie
d 
fo
od
s
no
 
↑
de
 B
at
lle
 J 
(2
00
8)
97
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
Ju
nk
 fo
od
 
↑
M
ar
co
s L
G 
(2
00
7)
99
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↑
Gu
tié
rr
ez
-D
el
ga
do
 R
S 
(2
00
9)
10
8 
Cr
os
s s
ec
tio
na
l
6-
14
 c
hi
ld
re
n
no
 
↑
Pe
ña
ra
nd
a 
A 
(2
01
2)
15
7 
Cr
os
s s
ec
tio
na
l
13
-1
4 
ch
ild
re
n
↑
N
ag
el
 G
 (2
01
0)
11
3 
Cr
os
s s
ec
tio
na
l
8-
12
 c
hi
ld
re
n
Bu
rg
er
↑
Epidemiologic studies of the risk factors of allergic rhinitis 41
Jurgita Saulyte Introduction 
Ta
bl
e 
2.
 C
on
t.  
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
 
Ta
m
ay
 Z
 (2
01
3)
12
9 
Cr
os
s s
ec
tio
na
l 
13
-1
4 
ch
ild
re
n 
Ha
m
bu
rg
er
 
↓
 
Hi
ja
zi 
N
 (2
00
0)
11
6 
Cr
os
s s
ec
tio
na
l
Ch
ild
re
n,
 a
do
le
sc
en
ts
↑
Li
ve
r 
Hu
an
g 
SL
 (2
00
1)
11
7 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
Bu
tc
he
r's
 m
ea
t 
↑
↑
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
no
M
ea
t 
Hu
an
g 
SL
 (2
00
1)
10
5 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
no
 
↑
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
Ro
se
nk
ra
nz
 R
R 
(2
01
2)
11
1
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
↑
↑
M
iy
ak
e 
Y 
(2
01
2)
13
5  
20
07
-2
00
8 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
↑
Li
 J 
(2
01
2)
11
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↑
Pe
ña
ra
nd
a 
A 
(2
01
2)
15
7 
Cr
os
s s
ec
tio
na
l
13
-1
4 
ye
ar
s
↓
N
ag
el
 G
 (2
01
0)
11
3 
Cr
os
s s
ec
tio
na
l
8-
12
 y
ea
rs
Bu
rg
er
↑
Po
ul
tr
y 
Ro
se
nk
ra
nz
  R
R 
(2
01
2)
11
1 
Cr
os
s s
ec
tio
na
l 
Ad
ul
ts
 
↑
 
↑
Kc
al
 
Hu
an
g 
SL
 (2
00
1)
11
7  I
I 
Cr
os
s s
ec
tio
na
l
13
-1
7 
ye
ar
s
no
↑
 
El
lw
oo
d 
P 
(2
00
1)
11
5 
Ec
ol
og
ic
al
13
-1
4 
ye
ar
s
Kc
al
 fr
om
 c
er
ea
l, 
ric
e
↓
Et
ha
no
l  
(E
th
yl
 a
lc
oh
ol
) 
Ba
rr
os
 R
 (2
00
8)
98
 
Cr
os
s s
ec
tio
na
l
Ad
ul
ts
 
↑
As
sin
g 
K 
(2
00
7)
15
8 
Cr
os
s s
ec
tio
na
l
18
-3
5 
ad
ul
ts
Al
co
ho
l
↓
Be
nd
ts
en
 P
 (2
00
8)
15
9 
Co
ho
rt
20
-2
9 
ye
ar
 w
om
en
Al
co
ho
l
↑
 
Sh
ah
ee
n 
SO
 (2
01
4)
16
0 
Co
ho
rt
In
fa
nt
s u
p 
to
 7
 y
ea
rs
M
at
er
na
l c
on
su
m
pt
io
n 
of
 a
lc
oh
ol
 d
ur
in
g 
pr
eg
na
nc
y 
↓
↓
(n
ot
 si
gn
)
Epidemiologic studies of the risk factors of allergic rhinitis 42
Introduction Jurgita Saulyte
Ta
bl
e 
2.
 C
on
t. 
Fa
ct
or
 
Au
th
or
 (y
ea
r)
 
Ty
pe
 o
f t
he
 
st
ud
y 
St
ud
y 
po
pu
la
tio
n 
 
(a
ge
 if
 sp
ec
ifi
ed
) 
Sp
ec
ifi
c 
fo
od
s (
if 
sp
ec
ifi
ed
) o
r 
sp
ec
ifi
c 
co
nd
iti
on
 
Al
le
rg
ic
 
rh
in
iti
s 
As
th
m
a 
Al
le
rg
ic
 
di
se
as
es
 in
 
ge
ne
ra
l*
 
Eg
gs
 
M
iy
ak
e 
Y 
(2
00
7)
12
7  
20
01
-2
00
2 
ye
ar
 st
ud
y 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
no
 
N
ut
s 
Fa
rc
hi
 S
 (2
00
3)
10
7 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↑
Ce
re
al
s 
M
ar
co
s L
G 
(2
00
7)
99
 
Cr
os
s s
ec
tio
na
l
6-
7 
ch
ild
re
n
↑
Ro
se
nk
ra
nz
  R
R 
(2
01
2)
11
1
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
Br
ow
n 
br
ea
d 
↓
↓
W
ijg
a 
AH
 (2
00
3)
11
4 
Co
ho
rt
2-
3 
ch
ild
re
n
Br
ow
n 
br
ea
d 
↓
Ri
ce
, P
as
ta
Gu
tié
rr
ez
-D
el
ga
do
 R
S 
(2
00
9)
10
8 
Cr
os
s s
ec
tio
na
l
6-
14
 c
hi
ld
re
n
no
 
Vi
rt
an
en
 S
M
 (2
01
0)
13
4 
Co
ho
rt
In
fa
nt
s u
p 
to
 5
 y
ea
rs
O
at
s
no
 
↓
So
y 
N
ag
at
a 
C 
(2
00
8)
16
1 
Co
ho
rt
Ad
ul
ts
So
y 
iso
fla
vo
ne
s
no
M
iy
ak
e 
Y 
(2
00
5)
16
2 
Cr
os
s s
ec
tio
na
l
Ad
ul
t w
om
en
So
y 
iso
fla
vo
ne
s 
↓
 (n
ot
 si
gn
)
↑
 - 
in
cr
ea
se
s t
he
 ri
sk
; 
↓
 - 
pr
ot
ec
ts
; n
o 
- n
o 
sig
ni
fic
an
t a
ss
oc
ia
tio
n 
w
as
 fo
un
d;
  
(n
ot
 si
gn
) –
 w
ea
k 
as
so
ci
at
io
n,
 b
ut
 n
ot
 si
gn
ifi
ca
nt
, o
r h
av
e 
lo
st
 th
ei
r s
ig
ni
fic
an
ce
 a
fte
r a
dj
us
tm
en
t f
or
 c
on
fo
un
di
ng
 fa
ct
or
s.
 
*A
lle
rg
ic
 d
ise
as
es
 in
 g
en
er
al
 –
 a
to
py
, m
ea
su
re
d 
as
 a
lle
rg
ic
 se
ns
iti
vi
ty
 (I
gE
 a
nd
/o
r S
PT
 m
ea
su
re
d)
.
Epidemiologic studies of the risk factors of allergic rhinitis 43
Jurgita Saulyte Introduction 
Introduction  Jurgita Saulyte 
Epidemiologic studies of the risk factors of allergic rhinitis 44 
Fats 
The effect of a diet rich in fat is widely analyzed in recent studies. Nevertheless, 
it is difficult to give a general picture of the effect of fat, because different types 
of fatty acids may act in opposite directions in the human body systems. Some 
fatty acids are described as having a protective effect on allergic rhinitis (for 
example omega-3), while others (such as omega-6 and omega-9) usually have 
no effect or are related to increased risk of allergy. Moreover, results within the 
same groups of fatty acids use to vary between studies as well. However, most 
of these studies are cross-sectional and results should be interpreted with 
caution, since this study design does not establish a relation between cause and 
effect properly.  
Depending on the length of their chain, fatty acids are divided in three main 
groups: saturated, monounsaturated and polyunsaturated. There are two 
essential fatty acids in the human nutrition that are required by the body but 
which cannot be produced in sufficient quantity from other substrates, and 
therefore must be obtained from food: alpha-linolenic acid (one of the omega-3 
fatty acids) and linoleic acid (one of the omega-6 fatty acids). 
Generally, intakes of saturated, monounsaturated and total fats (especially 
palmitoleic and oleic acids) are positively associated with increased risk of 
allergic sensitization and manifestation of atopic diseases like allergic 
rhinitis.100,150,152 Usually food of animal origin food such as meat, butter, milk 
and cheese are the main source of these saturated and monounsaturated fatty 
acids. The role of polyunsaturated fatty acids is controversial and depends on 
the length of the chain.  
Polyunsaturated fatty acids 
There are two main families of polyunsaturated fatty acids: omega-3 and 
omega-6. According to recent studies, some of the omega-6 polyunsaturated 
fatty acids (especially arachidonic acid) are related to an increased risk of 
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allergic rhinitis,133,153 while omega-3 polyunsaturated fatty acids act to oppose 
the action of omega-6 and are inversely associated with the risk of allergic 
sensitization and allergic rhinitis.100,133,143 Polyunsaturated fatty acids are 
essential in ensuring the correct environment for the function of membrane 
protein, by maintaining membrane fluidity and regulating cell signaling, gene 
expression and cellular function. It was suggested that through these actions 
polyunsaturated fatty acids can actually influence the functioning of the 
immune cells and thus could have an impact on the development and 
manifestation of atopic diseases.155 One of the key links between these fatty 
acids and the immunological processes related to atopy may be via eicosanoids, 
which are signaling molecules and are derived from either omega-3 or omega-6 
fatty acids. Eicosanoids act on inflammatory cells, smooth muscles and 
epithelial cells, and thus are strongly implicated in different immunologic 
features and clinical manifestations of atopic disease.  
The main dietary sources of omega-3 are seeds oils, such as flax and hemp, and 
all type of marine food, including marine algae. This may be one of the reasons 
why a higher amount of fish in the diet is protective against allergic rhinitis.133 
Early age at introduction of fish in the regular diet was even dose dependently 
associated with a decreased risk of allergic rhinitis,134 and reduction of atopy or 
allergy risk ranged between 22% and 80% with higher consumption of fish.133  
Most often, omega-6 polyunsaturated fatty acids are linked to an increased risk 
of allergic rhinitis via increased potential to produce pro-atopic and pro-allergic 
eicosanoids, derived from arachidonic acid (C20:4).95,145,148,150,152,153 Omega-6 
polyunsaturated fatty acids also participate in the production of E2 
prostaglandin, a derived product that shifts the Th1/Th2 balance in the Th2 
direction, which favors allergic diseases such as allergic rhinitis.100 On the other 
hand, a higher production of prostaglandin E2 and prostaglandin I2 also is 
associated with inhibition of allergen-induced inflammatory responses, what 
consequently could play a role in the decrease of allergic conditions like 
rhinitis.144 The role of omega-6 is not clear enough, and up to now studies that 
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analyses impact of consumption of omega-6 fatty acids on allergic rhinitis or 
atopy in general vary between protective and harmful effects. (Table 2) 
In contrast, omega-3 polyunsaturated fatty acids, such as eicosapentaenoic acid 
(C20:5 n-3), inhibits the conversion of arachidonic acid (20:4 n-6) to 
prostaglandin E2 and leukotriene B4, oppose the action of omega-6 and, thus, is 
negatively associated with allergic rhinitis.100,133 This biological mechanism of 
opposite actions of omega-6 and omega-3 polyunsaturated fatty acids suggests 
that the risk of allergic rhinitis increases with an increasing ratio of omega-
6/omega-3 intake. However, after summarizing the published data, no 
substantial association between the ratio of ingested omega-6 and omega-3 
polyunsaturated fatty acids and allergic rhinitis or sensitization may be drawn 
since results are contradictory (table 2). Usually, in a typical western diet, the 
proportion of omega-6 is much higher than that of omega-3 polyunsaturated 
fatty acids. Furthermore, it was disclosed that the daily intake of omega-6 
polyunsaturated fatty acids increased over the second half of the twentieth 
century, what relatively overlaps with increasing prevalence of atopy and its 
clinical manifestations.133  
Unlike omega-3 and omega-6 fatty acids, omega−9 are not classified as essential 
fatty acids. They are component of olive, macadamia nuts, rapeseed and some 
other oils. Most of the published studies found no effect of these fatty acids on 
the development of allergic rhinitis symptoms. (Table 2). However, oleic acid 
(18:1 n-9), one of the most important components of the omega-9 group, was 
related with increased risk of allergic rhinitis in a few studies.100,150 
Mediterranean diet 
The Mediterranean diet is defined as a dietary pattern usually used among the 
populations around the Mediterranean Sea. It is reported as a model for healthy 
eating and better quality of life.163,164 Common components of the 
Mediterranean diet include high monounsaturated/saturated fat ratio; high 
consumption of vegetables, fruit, legumes, and grains; rich in fish and seafood; 
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and moderate consumption of milk and dairy products.165,166 The 
Mediterranean diet is then rich in both antioxidants and cis-monounsaturated 
fatty acids. Most of the studies have found that good adherence to this diet 
protects from allergic rhinitis. (Table 2) Typically these studies were conducted 
in children and adolescents, indicating protecting role for atopic diseases in the 
first years of life or even later in life.96,164 
Minerals and vitamins 
No firm conclusion can be drawn in relation to minerals and vitamins. The 
beneficial effects of antioxidants on human health are well known, however, 
different vitamins with antioxidant activity were found to act diversely with 
regard to allergic rhinitis symptoms. (Table 2) Vitamin E is revealed to have a 
protective effect on allergic diseases, while high consumption of beta-carotene 
increases the risk of allergic rhinitis according to most studies. Vitamins A and 
C do not show any substantial effect on allergic rhinitis, and only asthma and 
atopy were found to be less prevalent in subjects consuming more of these 
vitamins. The most probable explanation could be that some of the substances 
can act as either antioxidants or pro-oxidants, depending on the circumstances. 
(Herbert, 1996) However, fruits and vegetables protect against allergic rhinitis, 
according to most studies. Early supplementation with multivitamins during 
the first years of life was also associated to reduced risk of allergic rhinitis later 
at school age.167  
Studies that analyze the effect of specific minerals on the occurrence of atopic 
diseases are scarce. Apparently, a higher consumption of minerals tends to 
protect against allergic disease.  
Fast food / Food additives 
High consumption of fast food was reported to increase the risk of rhinitis and 
asthma symptoms in children and adolescents. Respiratory allergic diseases in 
children have been correlated with frequent consumption of hamburgers, salty-
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snack eating and frequent takeaway food consumption. These associations were 
more significant in children with sedentary lifestyle, such as watching 
television or playing video games. It was suggested that dyes and 
preservatives, used widely in this kind of food, can act as occupational 
allergens and contribute to the induction of rhinitis symptoms.38,168,169 
Non-allergic mechanism of food induced rhinitis 
Some food items and alcoholic beverages may induce rhinitis symptoms by 
unknown, non-allergic mechanisms.1 For example, some spicy foods such as 
red pepper can induce rhinorrhoea probably because they contain capsaicin, 
which stimulates sensory nerve fibres inducing them to release tachykinins and 
other neuropeptides.170 Rhinitis caused by this type of triggers is very rare and 
is called food-induced rhinitis.1,167,171,172 
Alcohol consumption  
Despite the lack of data regarding alcohol consumption and atopic diseases, 
epidemiologic studies suggest that alcoholic beverages have an influence on 
allergic sensitization.1,173,174 It was reported that the risk to have positive skin 
prick test tended to increase with increasing consumption of alcohol, although 
these results were not statistically significant.174 According to one cohort study 
conducted in women, with a follow up period of 7.8 years, alcohol consumption 
was positively associated with the risk of developing perennial allergic rhinitis 
(adjusted odds ratio (OR) 1.78 (95% CI, 1.13-2.80) for women drinking more 
than 14 drinks/week), while there was no association between alcohol 
consumption and seasonal allergic rhinitis.159 In cross sectional study of adult 
men and women, higher amounts of alcohol consumed were inversely 
associated with occurrence of allergic rhinitis symptoms.158 Authors explain 
that the observed negative association may be a healthy-drinker effect: having 
respiratory symptoms may cause changes in the behavior towards alcohol 
consumption and the tendency to avoid it. No evidence was found that prenatal 
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alcohol exposure increases the risk of allergic rhinitis and asthma in 
childhood.160 
Smoking 
Smoking is related to numerous diseases. Indeed, the fact that almost 80% of 
European children and adolescents are exposed to second hand tobacco smoke 
supposes an important Public Health problem.175  
A number of studies have examined the association between smoking exposure 
and allergic disorders, including allergic rhinitis. However the results are 
conflicting and divide into three parts: revealing that smoking increases the 
risk, that there is no effect or even those, proclaiming the preventive effect of 
smoking on allergic rhinitis.159,176-178 Despite these findings, it seems that age 
may have an essential role as a modifier of the relation between smoking and 
allergy. We have carried out a systematic review and meta-analysis of active 
and passive smoking and the risk of allergic rhinitis, allergic dermatitis and 
food allergies. The risk of allergic rhinitis was modestly increased only in 
children for both active and passive smoking, while in the adult population the 
association was weak.179 This finding suggests that, in countries where smoking 
is frequent, 14% of allergic rhinitis among children may be attributable to active 
smoking. The mechanism involved is that smoking increases nasal responses to 
allergen in atopic subjects and increases IgE, immunoglobulin G4 (IgG4), and 
post-allergen histamine levels in nasal lavage fluid.180,181 The immaturity of the 
respiratory, nervous and immune systems of children makes them more 
vulnerable to the harmful health effects of tobacco smoke.182 Furthermore, 
smoking facilitates sensitization to perennial indoor allergens, such as animal 
dander, as well as to some outdoor allergens such as pollen.183 
Environmental factors 
Indoor and outdoor air pollutants are those elements of the environment that 
influence the presence of specific allergens, which are the targets of the IgE-
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mediated immune response.181 Improvement in the socioeconomic status of 
individuals is associated with improvement in lifestyle and greatly modernized 
domestic and professional working conditions, especially of individuals who 
spend more time indoors. There are evidences that an association exists 
between the time spent indoors and the changes in patterns of sensitization to 
allergens.184 Outdoor pollution has a significant influence, especially since the 
transport-related carbon emissions from growing motorized land vehicles and 
aviation are raising constantly.185 The exploitation of fossil fuels is inherent to 
modern life and has been a key element of the rapid technological, social and 
cultural changes of the last 250 years.186 Although such changes have brought 
considerable benefits, this exploitation has also contributed to a burden of 
illness, such as allergic disorders, through pollution of local and regional 
environments. These findings could confirm the observations made years 
earlier among migrant populations in the United Kingdom.187 In the late 1960s 
Morrison Smith with colleagues reported that the prevalence of asthma in 
Asian and West Indian children, who were born in the United Kingdom, were 
very similar to those of English children. However, the prevalence in immigrant 
children, who were born in their native countries, were generally much lower 
than those of children born in the United Kingdom. These data suggested that 
environmental events occurring very early in life, perhaps shortly after the birth 
have an impact on development of allergic conditions, such as allergic rhinitis 
and asthma in children, and environmental and lifestyle changes, implying 
more polluted environment, may be one of the crucial factors.  
Studies, that have been analysing the sensitization to the major indoor and 
outdoor allergens, have indicated that most common ones in patients with 
allergic rhinitis are: house dust mites, mould, pollen and animal dander.188-191 
Which allergens – from indoor or outdoor environment – are more common in 
allergic patients, depends also on living area. Urban populations may be less 
frequently sensitized to pollens, but more frequently sensitized to cockroach 
and other indoor allergens compared with residents from rural areas.192,189  
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Indoor environment 
The most common indoor allergen, associated with allergic rhinitis is house 
dust mite, the effect of which rises with increasing exposure level.41,44,193-195 
Other factors, such heating type, temperature, or ventilation, have a significant 
influence on the amount of dust mite indoors. It was observed that a constant 
warm and humid climate yields to proliferation of dust mites and molds.191,196 
Carpets at home, as well as stuffed toys, were also related with increased risk of 
allergic rhinitis among children, probably due to their elevated concentration of 
house dust mites and other allergens.197,198 
Mold patches were also revealed as an important source of indoor 
environmental allergens and were associated with a significant increase in the 
risk of allergic rhinitis in children.197  
Cockroaches are considered to be important vehicles of inhaled indoor 
allergens.188,197,199,200 The highest levels of cockroach allergens at homes were 
reported in dust samples collected from the wooden houses of urban slums.199  
Anti-mouse IgE-carrying children were found to be at a higher risk of rhinitis 
and atopy.201 However, other studies did not confirm the finding that early life 
mouse exposure has an impact on developing allergic rhinitis or asthma.202 
The effect of feather bedding is associated with inconsistent results: some 
studies found that it significantly increases the risk of allergic rhinitis 
symptoms,38 while others link it to fewer allergy symptoms.85 
It was proved that air conditioning may prevent against contamination with 
indoor allergens.203 Patients living in households without air conditioning were 
at greater risk of mold sensitization.204 Mechanical ventilation in dwellings was 
also found to be beneficial for the prevention of allergic rhinitis symptoms, 
while multiple sealing of buildings showed a direct association with allergy 
symptoms.205 It was shown that proper indoor ventilation may reduce the 
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effects of outdoor air pollution at homes: there were no associations found 
between traffic densities and allergic rhinitis symptoms in children sleeping in 
air-conditioned homes, what suggests that appropriate ventilation can mitigate 
traffic pollution problems.203  
Despite the existence of studies that showed that wood heating and direct 
heated electric radiators are associated with increased risk of allergic 
respiratory symptoms,205 other studies denied this fact. Heating with wood or 
coal and biomass were significantly related with fewer symptoms of allergic 
rhinitis.85,191,206 The hygiene hypothesis was proposed as a possible explanation: 
the incomplete combustion of coal and wood during heating releases 
byproducts with well-known adverse health effects, hence increasing the risk of 
respiratory infections.207-209 These infections might thus afford protection 
against allergic rhinitis and other allergic disorders, such as asthma, since 
activated Th1-type immune response may shift the balance and reduce Th2-
type allergen-induced response.85 A protective effect of infections may also 
partly contribute to a lower prevalence of these allergic conditions in some 
countries, as may explain the differences in prevalence between rural and urban 
areas.30,44,191,210,211 
Outdoor environment (pollution) 
With modernization of life the problem of outdoor pollution becomes more 
worrying in all aspects. It is well known that pollutants may play a direct and 
indirect role in the pathophysiology and the development of allergic 
diseases.38,198,212,213,214 It was found that patients with weakly positive skin prick 
tests for inhaled allergens may be more susceptible to the environmental factors 
as air pollutants may increase the risk of allergic inflammation in the nasal 
airway.216,217 
City life was associated with a higher prevalence of allergic rhinitis compared 
to country lifestyle.218 Recent studies revealed that the prevalence of allergic 
rhinitis is higher for people living near air-polluting factories or mines, as well 
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as in areas with high exposure to truck traffic. This is probably due to pollutants 
such as nitrogen oxide (NOx) and carbon monoxide (CO).38,85,203,216,218,219,220 A 
high annual average concentration of sulphur dioxide (SO2), carbon monoxide 
(CO) or nitrogen oxides (NOx) was significantly associated with increased 
prevalence of allergic rhinitis in children and adults.221-228 Exposure to increased 
ozone (O3) levels in summer was also associated with increased risk of hay 
fever in children and adults and this association with allergic children's 
symptoms was stronger in urban zones, compared to small metropolitan and 
rural areas.221,226,229,230 Nevertheless, not all studies succeeded to find any 
relationship between air pollutants such as sulphur dioxide (SO2), nitrogen 
dioxide (NO2) or high ozone (O3) levels with increased risk of allergic rhinitis 
in children population.223,224,229 
Studies show that polyaromatic hydrocarbons in diesel exhaust particles can 
enhance production of IgE, however other studies failed to find evidences that 
shows that elemental carbon, attributable to traffic, may have an influence on 
developing allergic rhinitis symptoms.195  
Particulate matter (PM) of diameter of ≤ 2.5 micron was significantly associated 
with increased prevalence of allergic rhinitis in children,229,231,232 while particles 
of larger diameter, of up to 10 micron, in the surrounding environment were 
not always significantly related to increased risk of allergy.223,224,233-235 Besides, 
most of these associations are statistically significant among children and those 
who had spent most of their lives in the same community only. 
It was found that living within 100 meters from a road with a traffic intensity of 
more than 10 cars/min (24 hour mean) correlates with the prevalence of allergic 
rhinitis and current asthma in adults.236 A distance-dependent relationship was 
identified, with the highest risk for children living less than 50 meters from 
busy streets.231 However, living within 150 meters from a major road was not 
significantly associated with an increased risk of any of the allergic disorders in 
any age group.237 
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It was disclosed that air pollution from car exhaust products have stronger 
impact on developing of allergic rhinitis symptoms than pollution from heating 
with coal.238 The prevalence of allergic rhinitis, asthma, and positive skin prick 
tests to aeroallergens was found to be lower in regions with high degree of air 
pollution with sulfur dioxide produced by coal (2.7%, 3.9%, and 18.2%) than in 
those polluted by automobiles (8.6%, 5.9%, and 36.7%).  
The environmental pollution with allergens plays an extremely important role 
in the first few months of life, since it is the most sensitive period, during which 
inhaled exposure to certain allergens may predispose to the subsequent 
development of atopic respiratory disease.239 Subjects born in the pollen season 
(March to April) have been shown to be at higher risk of being sensitized to 
birch pollen.195 Increased risk to develop grass pollen allergy was found in 
subjects born during grass pollen season (May to June).239 Increased 
concentration of ragweed particles in the air was directly related with increased 
average of daily physician visits for allergic rhinitis but, globally, outdoor air 
pollution was found to be a poor predictor of physician visits for this condition 
in adults.240 The frequency of sensitisation to pollens was reported to be higher 
in allergic population living in urban areas, while for indoor aeroallergens, such 
as moulds mixture and cat and dog dander, it was similar in both.241  
Hygiene hypothesis 
The so-called hygiene hypothesis was first suggested by Strachan in 1989, who 
suggested that atopic diseases, such as asthma and allergic rhinitis, are less 
prevalent in children from large families, where the probability to transmit 
infection by unhygienic contact with older siblings is higher.73 This theory was 
approved by a large majority of epidemiological studies over the world,30,195,242-
244 although other studies failed to confirm this finding.38,211 A study conducted 
in Germany disclosed that children from small families (up to three people) 
who began to attend day nursery at an older age had higher prevalence of 
atopy than those who started to attend it at a younger age.243 However, age of 
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entry to day nursery had no effect on atopy if children were from families with 
more than three family members.  
One more confirmation of the hygiene hypothesis has been provided later by 
comparative analysis of various regions in East and West Germany, after the 
fall of the Berlin Wall.245 Striking differences were noted between regions, with 
higher prevalence of atopy (i.e., allergic rhinitis, asthma) and atopic 
sensitization in West Germany, which was much more economically advanced. 
According to this, infections with viruses and perhaps other intracellular 
organisms influence the immune response. The hygiene hypothesis is based on 
the observations that Th1 responses induced by microbial stimulation can 
counterbalance allergen-induced Th2 responses.72 
According to the hygiene hypothesis, increased risk to develop allergic diseases 
is related with factors such as immunization with a variety of vaccines, wide 
use of antibiotics and paracetamol in infants and young children.38,66,246-248 
Meanwhile, acute gastroenteritis in infancy was related with decreased risk of 
allergy later in life: microbial stimulation of the gut may induce a subtle 
inflammation and secretion of mucosal IgA, which participates in antigen 
elimination. High intestinal IgA in early life was associated with minimal 
intestinal inflammation and reduced risk for IgE-associated allergic diseases 
such as eczema, food allergy, asthma, and rhinitis.249 However, this theory is 
applicable only in children, since it was not confirmed in adults.250 
Despite all these findings, some authors maintain that the hygiene hypothesis 
has to be specified much more precisely, with respect to some other criteria, 
such as type of the microorganism (parasites, bacteria, virus, and fungus), type 
or subtype of disease (IgE-associated or ‘intrinsic’) and type of contact.251  
Farming lifestyle 
In line with the field of the hygiene hypothesis, farming lifestyle, especially 
with contact to livestock, was related to a protective factor against development 
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of allergic disorders such as rhinitis in children and adults.128,210,211 It was found 
that children growing up on a farm were less likely to be sensitized to common 
aeroallergens and to suffer from allergic rhinitis than children living in the same 
villages but in non-farming families.252 Living in a farm in childhood is 
associated with a long term risk reduction: those adults who spent their 
childhood in a farming surrounding had significantly less atopic diseases later 
in life compared to those who spent their childhood in the city.253 However, 
some parts of the world, like Turkey or New Zeeland, show a greater 
prevalence of allergic rhinitis in rural areas than in urban.191,254 These 
discrepancies could be explained by differences in culture, ethnic origin, style of 
farming and behaviour. Indeed, it was found that levels of cat and dog 
allergens in the mattress dust were much higher in those belonging to girls than 
on those used by boys.194 
Pets 
The association between pet ownership and the risk of allergic rhinitis is 
contradictory. The hypothesis that having a pet at home increases the risk of 
allergic rhinitis was approved by number of studies.86,191,210,255 While, according 
to some other investigators, an independent inverse association was found for 
early-life exposures to indoor and outdoor animals and development of allergic 
disorders, including allergic rhinitis.256-260 Nevertheless, some studies found a 
protective relationship only with close contact to cats while for dogs’ keepers 
this association was significant only for asthma.254,261 Selection bias may have 
played a role in the existence of discrepancies between studies as it is likely that 
people with allergic symptoms tend to avoid contact with animals. 
Allergen movement from the native source to various surfaces and even 
unusual places that surround us every day is widely reported and should be 
taken into account. It was revealed that, although the concentration of cow 
dander allergen was found to be higher in stables, it was noticeable in dust 
samples from living-rooms and mattresses as well.262 Similarly, households 
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with exclusively outdoor dogs had significantly higher levels of dog allergen at 
home than homes without any animals at all.263 Very similar results were 
reported for cats’ allergens.262 This transporting, perhaps, happens most likely 
due to adherence on skin and clothing, although wind or air masses also may 
play a role.  
All these allergens that act directly, together with indirect factors that enhance 
the conditions for outdoor allergens to penetrate the houses and for indoor 
allergens to remain inside may act as risk factors for allergic rhinitis and should 
be taken into account when developing preventive measures.  
Social class 
The most recent studies show that the prevalence of allergic rhinitis increases 
with the higher social class of the family.72,211,264, The Tucson Children’s 
Respiratory Study showed a higher prevalence of allergic rhinitis among 
children whose mothers had more than a high school education.33 It was 
suggested earlier, that the ‘psychological environment’ created by the western 
lifestyle with its emphasis on maintaining sanitary conditions, may have 
interfered in the development of a normal immunity and influenced the 
development of atopic sensitization and diseases.245 The prevalence of atopic 
diseases was found to be significantly higher among children living in a bigger 
apartment or having more rooms in their homes.211 Furthermore, mud flooring 
was associated with reduced risk of allergic rhinitis in children,257 while living 
in a house made of concrete was significantly associated with an increased risk 
of allergic rhinitis symptoms.38 
Thus, according to the latest studies, city life, within a small family, high social 
class and exaggerated sanitary standards in infancy may increase the risk of 
developing atopic conditions such as allergic rhinitis later in life. However, it 
was suggested that socioeconomic status may merely reflect microbial 
contamination of water, food, and poorer housing conditions, and current 
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evidence regarding associations with common specific and non-specific 
infectious illness neither refutes nor supports the hygiene hypothesis.72 
1.6. CONTROL 
In accordance with the fact that allergic rhinitis is very common and still widely 
untreated or treated inadequately, education is needed in order to increase 
early recognition of the symptoms and to apply early treatment.   
According to recent studies, many allergic patients lack understanding of the 
nature of allergic rhinitis and its associated risks of respiratory complications, 
comorbid diseases, losses in productivity and in health related quality of 
life.35,58,69,265 In order to achieve maximum therapeutic responses, the 
appropriate education of patients and their family members and compliance are 
essential after diagnosis and initiation of therapy.1,11 The information of the risk 
of comorbid conditions and complications such as asthma, recurrent nasal 
polyps, sinusitis, and chronic otitis media should be explained. 
Identification and reduction of exposure to allergens is an essential part of the 
management of allergic rhinitis. Allergen avoidance was recommended as an 
integral part of a management strategy for allergic rhinitis and asthma by ARIA 
Workshop Group and the World Health Organization.1,11,266 Allergen transport 
from the outdoor to indoor, especially to bed, must be prevented by optimizing 
hygiene by measures such as face washing, keeping coat and cap at entry hall, 
using dust mite impermeable mattress covers, removing carpets from 
bedrooms.  
The most recommended pharmacotherapy for allergic rhinitis is intranasal 
corticosteroids and antihistamines, which improve both nasal symptoms and 
pulmonary function.81 However, the safest recognized treatment is 
immunotherapy, the use of which in children could significantly reduce allergic 
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rhinitis-related morbidity and its economic burden.267,268 Moreover, treatment 
with allergen immunotherapy lowers the risk to develop new asthma cases in 
adults with allergic rhinitis.269 Unfortunately, antihistamines are reported to be 
most often prescribed for allergic rhinitis patients, despite their side effects on 
the central nervous system that increase the risk of acute injuries.55,56,61,68 
Pursuant to recent findings, about 82% of allergic rhinitis patients are 
prescribed antihistamine (in combination or alone), and only for the rest 
immunotherapy is applied.35 
In conclusion, appropriate prevention and management of allergic rhinitis may 
prevent the development of asthma, as well as other serious complications, 
while on the other hand, management of food allergies and dermatitis in 
children may reduce the incidence of allergic rhinitis later in life. It was 
estimated that a three-part approach to management, which includes allergen 
avoidance, immunotherapy, and pharmacologic treatment, can reduce the 
progression of the inflammatory process and improve the patient’s quality of 
life. The ARIA Update recommendations reminds that patients with allergic 
rhinitis, particularly if persistent, should be evaluated for asthma, patients with 
asthma should be evaluated for rhinitis, and an effective combination strategy 
should be used to treat diseases of the upper and lower airways.1 
1.7. FUTURE CHALLENGES FOR INVESTIGATIONS 
Further studies on the incidence of allergic diseases are required in order to 
make conclusions on the real burden of this disease. In a large proportion, 
today’s knowledge on the disease is based solely on prevalence studies of cross-
sectional nature, inadequate for proper causal inference related to risk factors.  
The search of possible genes as risk factors for developing allergic rhinitis 
should be one of the main challenges of the future studies. 
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2. OBJECTIVES
The identification of modifiable risk factors of allergic rhinitis has important 
implications for the quality of life of patients as well as for the mitigation of the 
very costs of this disease. Changes in lifestyle such as those related to smoking 
and diet is crucial. Therefore we decided to conduct a comprehensive study in 2 
parts:  a meta-analysis and a case-control study with the following objectives. 
1. Using a meta-analysis of published studies, to determine the effect of active
and passive smoking on the development of allergic rhinitis.  
2. To determine the effect of a high dietary intake of proteins on the occurrence
of allergic rhinitis. 
3. To determine the effect of a high intake of antioxidants: β-carotene, vitamin
A, vitamin E, vitamin C, selenium and zinc on the occurrence of allergic rhinitis. 
4. To determine the effect of consumption of dietary omega-3 and omega-6
polyunsaturated fatty acids on the occurrence of allergic rhinitis.

3.1.  
A Systematic Review and Meta-Analysis on Active 
or Passive Smoking and Allergic Rhinitis

3.1.1. INTRODUCTION
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Allergic rhinitis, together with other closely related conditions like allergic 
dermatitis, food allergies and asthma, are extremely common diseases 
worldwide. Indeed, allergic rhinitis affects 10% to 20% of the general 
population in Europe and the US and up to 40% of children.1-3 The prevalence 
of allergy to any food varies between 3% and 35%,4 while that of allergic 
dermatitis reaches 20% in many countries.5 These diseases have profound 
consequences on the patient’s quality of life and imply a high cost both to the 
patient and insurance providers.6,7 Among infants, these costs reach more than 
US$4,000 per year per case of food allergy.8 Recent studies have suggested that 
these diseases are but one unique set of immunoglobulin-E (IgE)-mediated 
allergic conditions, linked by the common thread of ‘‘atopic march’’.9 This 
concept postulates that those conditions are a continuous state that starts with 
dermatitis and food allergy and eventually progresses to asthma and allergic 
rhinitis. Indeed, these diseases often co-exist in the same patient and can predict 
the occurrence of each other.10 
Worldwide, the prevalence of allergic diseases has increased substantially in the 
last few decades,11,12 which may have two explanations. On the one hand, 
increased clinician awareness, as well as patient and parental awareness, may 
have led to improved identification and increased case presentation to 
physicians.12 On the other hand, it is possible that this increase is due to 
changing exposure to known and unknown risk factors,13 and among these 
factors, smoking may play a role. An increased risk of allergic diseases among 
individuals exposed to tobacco smoke is biologically plausible as smoking is 
known to facilitate sensitization to perennial indoor allergens, such as those 
caused by furry animals, as well as to some outdoor allergens such as pollen.14 
Furthermore, smoking augments nasal responses to allergen in atopic subjects 
and increases IgE, immunoglobulin G4 (IgG4), and postallergen histamine 
levels in nasal lavage fluid.15,16 
Allergic conditions are, in general, more prevalent in children. A potential effect 
of smoking would have a considerable impact on public health due to the 
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frequency of exposure worldwide. Indeed, children and adolescents are 
exposed to secondhand smoke in a proportion that varies between 27.6% in 
Africa and 77.8% in Europe and approximately 14% of all children were 
exposed to maternal smoking during pregnancy.17,18 
Several studies have assessed the association between smoking exposure and 
allergic diseases. In each of the allergic conditions, results were conflicting and 
alternated between the harmful effects of smoking and protection,14,19-23 while 
some studies could not find evidence of any effect.24-26 
Except for a systematic review and meta-analysis examining the relationship 
between smoking and asthma in children,27 to our knowledge, there is no 
comprehensive meta-analysis that examines the evidence for a relationship 
between smoking and allergic conditions like allergic rhinitis. We, therefore, 
summarized the scientific evidence and carried out a meta-analysis on exposure 
to active and passive smoking and the risk of allergic rhinitis among adults and 
children/adolescents
3.1.2. METHODS
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Data sources and searches 
We searched databases from 1966 to end of February, 2013, to identify all 
potentially eligible studies. For Medline, we applied the following algorithm 
both in Medical Subject Heading and in free-text words: ("SEASONAL 
ALLERGIC RHINITIS" OR "ALLERGIC RHINITIDES, SEASONAL" OR 
"ALLERGIC RHINITIS, SEASONAL" OR "RHINITIDES, SEASONAL 
ALLERGIC" OR "RHINITIS, SEASONAL ALLERGIC" OR "SEASONAL 
ALLERGIC RHINITIDES" OR "POLLEN ALLERGY" OR "ALLERGIES, 
POLLEN" OR "ALLERGY, POLLEN" OR "POLLEN ALLERGIES" OR 
"POLLINOSIS" OR "POLLINOSES" OR "HAY FEVER" OR "FEVER, HAY" OR 
"HAYFEVER" OR "RHINITIS, ALLERGIC, NONSEASONAL" OR "RHINITIS, 
ALLERGIC, PERENNIAL") AND (SMOKING OR TOBACCO OR CIGARETT*). 
We used similar strategies to search Embase and LILACS (Latin American and 
Carribean database). We searched meeting abstracts using the ISI Proceedings 
database from its inception in 1990 to 2013. We also examined the references of 
every article retrieved and those of recent reviews of allergic rhinitis and 
smoking.16,28-33 We considered including any relevant article, independently of 
the language of the publication. Unpublished and ecologic studies were not 
considered. 
Study selection 
Studies were included if: 1) they presented original data from cohort, case-
control or cross-sectional studies (ecologic studies were not considered), 2) the 
outcome of interest was clearly defined as allergic rhinitis 3) one of the 
exposure factors was smoking, either by the subjects themselves or their 
relatives, 4) they provided estimates of odds ratio (OR), relative risk (RR), or 
prevalence odds ratio and their confidence intervals, or enough data to 
calculate them. If data on the same population were duplicated in more than 
one study, the most recent study was included in the analysis. When data for 
different types or levels of exposure were available in the same study, such as 
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passive smoking, active smoking, maternal smoking during pregnancy, we 
considered each type of exposure separately. We developed a standard data-
recording form in which we recorded authors, year of publication, study 
location, study design including whether ISAAC methodology was followed, 
sample size, outcome, outcome measurement details, effect estimator (OR, RR, 
other), effect estimate, 95% Confidence Intervals, and adjustment factors used. 
When further clarification was necessary, we attempted to contact the authors. 
We considered odds ratios as estimates of the Relative Risk.  
Quality assessment 
Study quality was assessed using a five-point binary scale specifically 
developed for this study. The scale is based on the Newcastle-Ottawa scale with 
modifications in view of standard guidelines and our own judgment.34 We used 
the following criteria labelled as “yes” or “no”: 1) whether assessment of the 
smoking habit included duration and/or quantity (yes) or else (no), 2) whether 
rhinitis diagnosis included clinical features and IgE or SPT measurements (yes) 
or was based on clinical examination only (no) 3) whether results were adjusted 
for age, sex and other potential confounders (yes), or else (no), 4) whether 
participations exceeded 80% of the people initially approached (yes) or else 
(no), and, finally 5) whether the target population was clearly defined (yes) or 
on the contrary, based on convenience sampling of subjects such as patients of a 
single consultation (no). Throughout this assessment, when the information on 
a specific item was not provided by the authors, we graded this item as “no”. 
We carried out a pooled analysis on those studies that fulfilled at least 3 criteria 
and compared with those that scored less than 3.  
Data extraction and quality scoring were performed independently by two 
reviewers (BT and JS) and results were merged by consensus. The results for 
quality scoring are presented in the annex I.  
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Data synthesis and analysis 
We weighted the study-specific adjusted log odds ratios for case control and 
cross-sectional studies, and log relative risks for cohort studies by the inverse of 
their variance to compute a pooled relative risk and its 95% confidence interval. 
For each study, we used the estimate of the effect measure that was adjusted for 
the largest number of confounders. 
We present both fixed-effects and random-effects pooled estimates but use and 
report the latter when heterogeneity was present, as in our main analysis and 
most subgroup analyses the random-effects model is generally thought to give 
more reliable results than the fixed-effects model, including a more 
conservative (wider) CI, when the studies being considered show a 
considerable degree of heterogeneity. Odds ratios from case-control studies 
were assumed to be unbiased estimates of the relative risk.35 
We used a version adapted to small samples of the DerSimonian and Laird Q 
test to check for heterogeneity.36 The null hypothesis of this test is the absence 
of heterogeneity. To quantify this heterogeneity we calculated the proportion of 
the total variance due to between-study variance (Ri statistic).36 Furthermore, 
we explored the origin of heterogeneity by restricting the analysis to subgroups 
of studies defined by study characteristics such as study design, type of 
exposure (active or passive smoking) and age of the participants 
(children/adolescents or adults). 
We assessed publication bias first, visually, using funnel plots and then, more 
formally, using the test proposed by Egger and colleagues.37 All analyses were 
performed with the software HEpiMA® version 2.1.3 and STATA version 12.38  
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The secondary analyses (children and adolescent’s population/adults, 
ISAAC/other, cohort and case-control studies combined/cross-sectional 
studies, high quality/low quality) were planned a priori. 
3.1.3. RESULTS 
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In total we identified 196 studies, published in 139 different articles and carried 
out in 51 countries, on active or passive smoking and allergic diseases at large 
that met our inclusion criteria. (Figure 1) The data from one study were 
obtained from the authors.39 We found 97 studies on allergic rhinitis.19,21,24,39-118 
A large majority of the articles retrieved initially were excluded either because 
they did not provide any effect measure or the outcome was allergy at large. 
Globally, heterogeneity was substantial overall and similarly high after 
stratification by design, quality features (including adjustment for confounders) 
and study population. Given the substantial heterogeneity, we focused on the 
random effects results, however the fixed effects analyses are presented for 
comparison and only discussed where they differ from the random effects 
results. 
Thirty-four studies on active smoking and 63 studies on second-hand smoking 
were available. (Tables 1 and 2, and Figures 2 and 3) The overwhelming 
majority of the studies assessed diagnosis through questionnaire and only 7 
studies used skin prick test or IgE measurements for the case 
definition.39,42,46,52,57,101,113 The study by Wright et al. measured skin prick test 
(SPT) reactivity but used a definition of physician diagnosed allergic rhinitis 
that included both SPT-positive and SPT-negative children.42 More than half of 
the studies used ISAAC criteria for the definition of allergic rhinitis. Finally, 11 
studies assessed maternal smoking during pregnancy.44,45,47-49,60,70,81,93,99,114 Table 
3 shows the results for associations between smoking and allergic rhinitis. 
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Figure 1. Flow diagram for study selection. 
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Active smoking  
Using random effects analysis, there was no significant association between 
active smoking and the risk of allergic rhinitis when all studies are considered 
(RR=1.02; 95% CI: 0.92-1.15). Using fixed effect analysis for all studies, there was 
a significant association between active smoking and risk of rhinitis (RR=1.06; 
95% CI: 1.03-1.08), however this may be explained by the considerable amount 
of heterogeneity due to differences in designs, case and exposure definitions 
and adjustment for confounders. It is remarkable that, under the fixed effects 
model, the result of the cross-sectional subgroup (RR=1.09; 95% CI: 1.06-1.12) is 
statistically significant and opposed to the result of the cohort studies subgroup 
(RR=0.87; 95% CI: 0.82-0.93).  When restricting the analysis to the 10 studies 
carried out on children and adolescents populations, active smoking was 
associated with an increased pooled relative risk of 1.40 (95% CI: 1.24-1.59). In 
further sub-group analyses, the association was significant in the studies that 
used the standardized ISAAC protocol (RR=1.50; 95% CI: 1.35-1.66), but not 
those that used their own protocol (RR=0.96; 95% CI: 0.88-1.08). A reverse 
association between active smoking and allergic rhinitis was observed in adults 
only (RR=0.90; 95% CI: 0.82-0.99) 
Passive smoking 
Using random effects analysis, there was a significant association passive 
smoking and allergic rhinitis (RR=1.10; 95% CI: 1.06-1.15). Similar findings were 
observed in subgroup analyses by adjustment for confounding variables 
(RR=1.07; 95% CI: 1.03-1.12 for full adjustment, RR=1.15; 95% CI: 1.04-1.27 for 
incomplete adjustment), quality scores (RR=1.10; 95% CI: 1.04-1.15 for high 
quality, RR=1.10; 95% CI: 1.02-1.19 for low quality), and for cross-sectional 
studies (RR=1.09; 95% CI: 1.05-1.14); however, there was no significant 
association between passive smoking and allergic rhinitis when restricting the 
analysis to cohort studies (RR=1.14; 95% CI: 0.96-1.34) or case-control studies 
(RR=1.14; 95% CI: 0.46-2.82). 
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Figure 2. Study-specific and random effects pooled risks of smoking and allergic rhinitis 
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Figure 3. Study-specific and random effects pooled relative risks of passive smoking and allergic rhinitis. 
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In subgroup analyses based on age group, a significant association between 
passive smoking and allergic rhinitis was observed in adults only (RR=1.17; 
95% CI: 1.03-1.32) and in children and adolescents (RR=1.09; 95% CI: 1.04-1.14). 
For maternal pregnancy smoking, there was no evidence for a significant 
increase in the risk of allergic rhinitis in the offspring (RR=1.07; 95% CI: 0.92-
1.28).  
Publication Bias  
The funnel plot of active smoking seems to be slightly skewed to the left, which 
indicates a potential lack of studies that favor a positive association of the 
disease with smoking. (Figure 4) However, the Egger’s test of asymmetry 
yielded a non-significant p-value of 0.27 and no hypothetical study was 
suggested as missing in the trim-and-fill procedure. The funnel plot for passive 
smoking (figure 5) and the corresponding results of the Egger’s test did not 
show any evidence of publication bias (p=0.53), but two new studies were 
imputed in the trim-and-fill procedure yielding a modified pooled relative risk 
of 1.10 (95% CI: 1.05-1.14). 
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Figure 4. Funnel plot of relative risk versus standard error of relative risk: allergic rhinitis, active smoking. 
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Figure 5. Funnel plot of relative risk versus standard error of relative risk: allergic rhinitis, passive smoking. 
Meta-regression 
The meta-regression with the pooled log relative risk as a dependent variable 
and the population variable as a moderator, introduced in the model as a 
dichotomous variable (adults/pediatric population), yielded the following 
results for the children and adolescents when compared to the adults for 
allergic rhinitis and active smoking: RR=1.55; 95% CI: 1.30-1.84; allergic rhinitis 
and passive smoking: RR=0.93; 95% CI: 0.81-1.06. These results suggest that the 
associations between allergic rhinitis with active smoking are significantly 
greater among children and adolescents than among adults. Although these 
meta-regression RRs were not statistically significant at a 95% level for passive 
smoking, in table 3 we present the results of children and adolescent 
populations as a subgroup both for active and passive smoking. 
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Sub-group Analyses in Children and Adolescents  
We calculated the random effects pooled relative risks for children cohort 
studies, then for children cohort studies and case-control studies combined. For 
cohort studies, passive smoking was not significantly associated with allergic 
rhinitis (RR=1.14; 95% CI: 0.96-1.34, nine studies), but the association of 
increased risk was significant for cohort and case-control studies combined: 
RR=1.17; 95% CI: 1.00-1.38, ten studies. 
Sensitivity Analysis 
To further evaluate the possibility that the results obtained for 
children/adolescents were due to publication bias, we assumed that cross-
sectional studies are the kind of studies that are most probably rejected by 
journals in case of null results and recalculated our pooled estimates under the 
following extreme assumptions: (1) published cross-sectional studies are only 
half of the studies of smoking and allergic rhinitis ever conducted among 
children, (2) all unpublished studies found an RR of 1, (3) the unpublished 
studies found the same prevalence of allergic rhinitis as the average of the 
published studies. Under these extreme assumptions, the random effects 
pooled estimates for active smoking still show a significant increase in risk: 
RR=1.16; 95% CI: 1.08-1.25. 
Summary of the results of smoking effect on allergic dermatitis and food allergies 
We also retrieved 91 studies on allergic dermatitis and eight on food allergy. 
Very modest associations were observed between smoking and allergic 
dermatitis and food allergies among adults. When all studies were analysed 
together, allergic dermatitis was associated with both active (random effects 
pooled RR=1.21; 95% CI: 1.14-1.29) and passive smoking (random effects pooled 
RR=1.07; 95% CI: 1.03-1.12). Among children and adolescents, both active and 
passive exposure to tobacco smoke was associated with a modest increased risk 
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for allergic dermatitis (random effects pooled RR=1.36; 95% CI: 1.17-1.46 and 
1.06; 95% CI: 1.01-1.11 respectively). Food allergy was associated with passive 
smoking (random effects pooled RR=1.43; 95% CI: 1.12-1.83) when cohort 
studies only were examined, but not when all studies were combined. 
3.1.4. DISCUSSION 
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In the overall population, active smoking was associated with a modest increase 
in the risk for allergic dermatitis but not allergic rhinitis, while passive smoking 
was associated with modest increases in the risks for both allergic dermatitis 
and allergic rhinitis. Among children and adolescents, we observed significant 
associations between both active and passive smoking and allergic rhinitis and 
allergic dermatitis, and passive smoking was associated with an increased risk 
for food allergy. In children and adolescents, while the observed increase in risk 
for allergic diseases associated with smoking was small, the findings are 
important given that to the prevalence of active and passive smoking in this 
population can be high. Worldwide, 14% of adolescents aged 13 to 15 are active 
smokers with some countries reaching a prevalence of 40%, and nearly 25% of 
the children who smoke have smoked their first cigarette before the age of 10 
years.119 Furthermore, in the US, more than one-third of children live with at 
least one adult smoker.120 In other parts of the world, passive exposure to 
tobacco among children is even higher as nearly half of children were exposed 
to tobacco smoke at home.121 On the basis of the figures above, in countries with 
high smoking prevalence we estimate that 14% of allergic rhinitis and 13% of 
allergic dermatitis are attributable to active smoking.122 Eliminating active 
smoking in children and adolescents would then prevent one in every seven 
cases of allergic rhinitis and one in every eight cases of allergic dermatitis.  
That age is an important effect modifier for the relation between tobacco 
exposure and risk of allergic diseases is biologically plausible. The US Surgeon 
General has suggested that the immaturity of the respiratory, nervous, and 
immune systems in children may make them vulnerable to health effects of 
smoking.123 Furthermore, unlike adults, children have limited options for 
avoiding exposure to second-hand smoke and are unable to reduce the quantity 
of products inhaled.123 
Our finding that maternal exposure is not associated with the risk of allergic 
diseases in the offspring confirms the results from a previous meta-analysis that 
focused on the risk of allergic sensitization measured through skin prick 
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positivity or IgE concentrations.30 It is possible that the lack of observed 
association is due to the existence of bias given that parents of children at high 
risk of allergy may selectively avoid smoking during pregnancy.  
The findings from our meta-analysis are subject to several limitations. The 
majority of studies were cross-sectional, a design that does not allow for causal 
inference and can overestimate relative risks given its reliance on prevalence 
ratios. When restricted to cohort studies our analyses showed that many of the 
results were no longer significant, especially for the subgroup analysis in 
children and adolescents. There is then some evidence that the findings may be 
impacted by study design.  
Residual confounding (confounding remaining after adjustment) may explain 
some of our findings. For some of our analyses, we were unable to detect 
meaningful differences in the results between studies that had incomplete 
adjustment for confounders and those with more complete adjustment for 
confounders and our findings were broadly similar when restricting the 
analyses to studies with higher quality scores. However, there are likely to be 
other factors, such as genetic factors that were not controlled for and may play a 
role in the relationship between smoking and allergic diseases. Although 
publication bias cannot be ruled out, its magnitude is likely to be low as shown 
by the robustness of our sensitivity analysis.  
Several studies assessed allergic diseases through self-report only, which can 
lead to misclassification of allergic and nonallergic conditions. Similarly, the 
findings are limited by measurement error in the smoking exposure given that a 
majority of studies assessed exposure to smoking in a qualitative fashion and 
often on a yes/no basis instead of using a quantitative assessment. 
Misclassification and measurement error in SHS assessment may result from a 
respondent’s lack of knowledge about current or past exposure, biased recall, 
whether intentional or unintentional, and the difficulty in characterizing an 
exposure in complex indoor environments.124 A standard set of items to identify 
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passive smoking in distinct settings is needed.125 If misclassification exists, it is 
probable that the outcome misclassification is not differential in regard to 
smoking and, similarly, measurement error in smoking assessment is not 
differential in regard to diagnosis. In this case, the results would be biased 
towards the null value, which means that the association with smoking 
observed in our meta-analysis is underestimated. 
In our subgroup analyses, we were unable to identify any factors that 
accounted for study heterogeneity. Given the high heterogeneity estimates, we 
focused our interpretation on the random effects estimates. The random effects 
model gives increased weights to the effect of small studies, which may 
introduce bias in the estimation. It is worth noting that for some of the analyses, 
the fixed effects and random effects estimates differ substantially; this may be 
due to differences in case or exposure definition and in adjustment for potential 
confounders.  
Our subgroup analyses found stronger evidence for associations between 
smoking and allergic diseases in children and adolescents than adults. 
Furthermore, our meta-regression suggested that the association between active 
smoking and allergic disorders is larger in children and adolescents than in 
adults, which advocates for a transient effect through life. This finding is in 
accordance with the “atopic march” concept that suggests that the sequence of 
sensitization which starts in childhood may show a tendency to spontaneous 
remission later in life.126 It is then plausible that sensitization to tobacco is 
mitigated by increasing age. Further research is needed to verify whether the 
association between smoking and risk of allergy in adults is similar for those 
who started smoking as an adult and those who started smoking during 
childhood or adolescents.  
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Annex I. Quality scoring of the allergic rhinitis studies 
Criteria:  
1. Smoking definition:
Duration – duration of smoking considered 
 “or” 
Number of cigarettes smoked (usually per day/per year) 
2. Determination of allergic rhinitis well defined, with one of these:
-SKP “or” 
- IgE “or” 
- Medical diagnosis 
3. Adjusted for:
- Sex 
- Age and  
- Any other 
4. Participation rate ≥ 80%
5. Target population clearly defined
Abbreviations: 
AS – active smoking 
SHS – second hand smoking 
SHS in Utero – mothers smoking during pregnancy 
SHS + in Utero – second hand smoking + mothers smoking during pregnancy 
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Annex II.  
Copy of the article “Active or passive exposure to tobacco smoking and 
allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a 
systematic review and meta-analysis”, published in the journal PLOS Medicine. 
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3.2. 
Dietary Intake of Proteins, Antioxidants and 
Polyunsaturated Fatty Acids and Risk of Allergic 
Rhinitis: a Case-Control Study 

3.2.1. INTRODUCTION
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Allergic rhinitis, in spite of its benign evolution, represents a global health 
problem. The identification of modifiable risk factors of allergic rhinitis is 
crucial in order to reduce its high economic cost and substantial impact on the 
quality of life of the patients and their relatives, as well as to apply effective 
preventive measures. 
Although allergic rhinitis is known to have genetic determinants,1 the 
prevalence increase, observed in the last decade, has occurred far too rapidly 
for genetic changes to explain it.2 Gene-environmental interactions were 
proposed recently as the most important risk factor for atopic diseases 
including allergic rhinitis.3,4 Changing industrialization, urbanization, economic 
development and market globalization have a significant impact on the health 
and nutritional status of populations, particularly in developing countries.5
These changes in diet and lifestyle are considered as the main determinant of 
the increase in prevalence of atopic conditions over the world. Nutrition is 
coming to the fore as a major modifiable determinant of disease including 
allergies, with scientific evidence supporting the view that alterations in diet 
may have strong effects, both positive and negative, on health throughout life.5
Existing studies regarding the relation between diet and allergic rhinitis yielded 
contradictory results. Further research is still required to establish the feasibility 
and efficacy of dietary manipulation as a public health measure to reduce the 
risk of allergic diseases.  
We, therefore, decided to conduct a multicenter case-control study in order to 
determine possible modifiable dietary risk factors of allergic rhinitis. 

3.2.2. METHODS
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3.2.2.1. Study Design 
A multicenter case-control study was carried out between January 2011 and 
October 2013. 
3.2.2.2. Study Population 
387 cases and 387 controls were recruited from 6 large pharmacies in 2 cities in 
Northwest Spain and from the pulmonology and allergology units of 2 main 
hospitals of the same cities: Santiago de Compostela and Pontevedra. The 
emergency care unit of the Hospital of Santiago de Compostela was also 
included for the collection of control subjects.  
3.2.2.3. Data Collection 
All participants were asked to answer a 4-page questionnaire (Annex I). Cases 
were selected from patients attending the hospital units for allergy symptoms. 
Also, pharmacy customers who were buying over-the-counter medicines for 
rhinitis symptoms such as antihistaminics and corticosteroids (complete list of 
medicines available at annex II) were invited to participate in the study as 
potential cases. Customers attending the pharmacy for any other reason than 
allergy or respiratory symptoms and who fulfilled our matching criteria were 
invited to take part in the study as potential controls. Hospital controls were 
subjects attending for reasons other than allergic or respiratory symptoms. We 
included subjects attending for injuries, cardiovascular and gastrointestinal 
diseases as well as for gynecological motives. Case or control status was 
confirmed by means of an algorithm as explained in the chapter “Disease 
assessment”. In each location (pharmacy or hospital unit), controls were age- 
and sex-matched to the cases on a one-to-one basis. 
The questionnaire consisted of a series of rhinitis symptoms, a medical history, 
a Food Frequency Questionnaire (FFQ) and questions on other lifestyle 
variables that could be potential confounders of the relation between diet and 
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allergic rhinitis. The questionnaire needed approximately 30 minutes to be 
completed. In the nutritional part we incorporated 7 food groups, asking to 
record the average frequency of consumption of each of 86 foods and beverages 
during last year. The questionnaire was anonymous in order to increase the 
response rate. Signed informed consent was obtained from all participants 
(Annex III). 
Additionally, we asked all participants to provide a sample of saliva for genetic 
determinations. However, as the study of genetic factors is beyond the scope of 
this dissertation that concentrates on modifiable environmental factors, results 
on genetic polymorphisms will not be presented here but in future publications. 
3.2.2.4. Disease Assessment 
To determine cases of allergic rhinitis, we used The Allergic Rhinitis and its 
Impact on Asthma (ARIA) questionnaire, together with criteria of the Joint Task 
Force on Practice Parameters.6,7,8 The participants were asked to record the 
presence of six main symptoms of rhinitis on the peak day of the current 
episode and to rate their frequency from 0 (no attack per day) to 4 (more than 
20 attacks per day). These symptoms were: nasal congestion, sneezing, runny 
nose, postnasal drip, itching of the nose and itchy or watery eyes. We also asked 
the participants to rate the thickness of their nasal secretion from 0 (very 
watery) to 4 (very thick), and its color from 0 (colorless) to 4 (green). A list of 
potential triggers of these symptoms was also suggested.  
After the validation of the outcome (see chapter “Validation of the outcome”), 
we required four criteria to define allergic rhinitis: (1) minimum symptom score 
of 4 out of 12 for three main symptoms of allergic rhinitis (nasal congestion, 
sneezing and runny nose) (2) consistency of nasal secretion from very watery to 
medium, (3) color of nasal secretion to be white or colorless, and (4) at least one 
of the irritants causing rhinitis symptoms should have been pollen, house dust 
mites or animal dander. We selected the cutoff point of 4 for the first criterion as 
this figure maximized the sensitivity and specificity of the allergic rhinitis 
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diagnosis in the concurrent validation substudy explained below. However, our 
main study results did not change substantially when we used other cutoff 
points. 
As allergic and non-allergic conditions often overlap in the same patient and 
the symptoms may be similar in both conditions,9,10 one of our aims was to 
disentangle allergic and non-allergic rhinitis cases and exclude the latter from 
our analysis. Subjects were considered as having non-allergic rhinitis if they 
reported: (1) a minimum score of rhinitis symptoms of 4 out of 12 (nasal 
congestion, sneezing and runny nose), (2) postnasal drip at least 6 times a day 
or a thickness score of nasal secretion from medium to very thick, and (3) 
rhinitis symptoms were triggered by either tobacco smoke, changes in 
temperature, high humidity or exposure to aerosol sprays. The criteria for the 
diagnosis of nonallergic rhinitis were based on clinical updates of the 
disease.10,11 
For the analysis of the risk factors of allergic rhinitis, we selected only those 
cases that did not have any coexisting non-allergic form of rhinitis. We did not 
differentiate between seasonal and perennial types of allergic rhinitis.  
Controls were selected from customers attending the pharmacy for reasons 
other than allergic and respiratory diseases. The control group included 
customers who sought medicine related to minor traumatic injuries, digestive 
disorders, high blood pressure, diabetes, antidepressants. We also included 
customers who were buying medications for their relatives.  
Occasional sneezing and rhinorrhea in the morning after exposure to cold and 
polluted air is considered to be a normal nasal response.7 We therefore assumed 
that some occasional nasal symptoms may be present in the healthy population 
and thus accepted controls with minor symptoms. Customers were selected as 
potential controls if (1) their score of rhinitis symptoms (nasal congestion, 
sneezing and runny nose) was 3 or less out of 12, (2) they did not have any 
subjective feeling or any confirmed diagnosis of rhinitis, (3) they did not use 
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any medication that could hide possible rhinitis symptoms such as medicines 
for asthma, and any type of mucolytic, decongestant and expectorant drug used 
for common cold, flu, bronchitis and sinusitis. We used the same criterion to 
select hospital-based controls.  
3.2.2.5. Exposure Assessment 
To assess the regular diet and obtain daily intakes of macro and micronutrients, 
together with daily energy intake, we used an 86-item semi-quantitative food 
frequency questionnaire which was developed based on the validated food 
frequency questionnaire in Spain.12 Participants were asked about their average 
frequency of consumption of standard portions of selected dietary items, 
representative of the local diet, during the last year. Each food frequency was 
reported with an eight-grade scale ranging from “never” to “more than three 
times a day.” To calculate the content of macro and micronutrients for each 
food item we used Spanish food composition databases that we completed with 
European and American sources when the data was not available in the Spanish 
sources.13-18
The variable of daily protein intake for each participant was created from all 
food items, calculating their content of protein. The same methodology was 
applied for calculation of other macro and micronutrient’s intake per day. 
Consumption of meat contains daily amount of all types of meat and meat 
products including offal. Daily consumption of dairy includes milk, all types of 
cheese, butter and yoghurts. Proteins of animal origin include only those that 
are from meat products, and proteins of vegetable origin consist only of those 
proteins that are provided by fruits and vegetables, including all types of cereal 
products, potatoes, beans and rice.  
We calculated the daily intake of the following antioxidants: β-carotene, 
vitamin A, vitamin E, vitamin C, selenium and zinc. Daily consumption of all 
fruits included: orange, grapefruit, tangerine, apples, pears, peach, apricot, 
cherries, banana, strawberries, kiwi, melon, watermelon, pineapple. Avocado 
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and olives also were considered as fruits. The variables of vegetable 
consumption consisted of the mean intake of carrots, beets, onions, eggplant, 
zucchini, pumpkin, asparagus, spinach, chard, leeks, tomatoes, lettuce, endive, 
peppers, cabbage, turnips, beans, peas and potatoes.  
Daily intake of omega 3 and omega 6 was obtained from the intake of fish and 
seafood, including, among others, mussels, crustaceans and octopus. Oil intake 
was calculated from the average consumption of olive oil or any other type of 
vegetable oil which was used for cooking or for dressing. 
An estimate of the total daily average alcohol intake was derived according to 
the Spanish Health Survey (ENSE 2011/12) using average ethanol content in 
100g of each type of beverage (10g for wine (red and white), 10g for beer and 
20g for spirits).19 
Cigarette consumption was assessed using the standard World Health 
Organization questionnaire.20 Smoking status categories were: never-smoker, 
ex-smoker, occasional smoker, and current smoker of 1–19, 20–40, or more than 
40 cigarettes a day. 
3.2.2.6. Data Analysis 
Those variables that did not follow a normal distribution were log-transformed. 
We then categorized them into tertiles or quartiles according to the width of the 
interval. Those variables the distribution of which remained highly asymmetric 
after logarithmic conversion were divided into categories with similar sample 
size. Crude and adjusted odds ratios and corresponding 95% confidence 
intervals of possible risk factors for allergic rhinitis were estimated by 
conditional logistic regression. 
Possible risk factors for allergic rhinitis that were considered in the analyses as 
candidates for potential confounders included level of education, history of 
asthma, history of dermatitis, familial history of allergy, body mass index, 
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energy expenditure in Kcal/hour, smoking habits, rural residency, alcohol 
consumption, contact with animals, and humidity in the house. We also 
considered additional adjustments for variables such as macro- and micro-
nutrients other than those considered as potential risk or protection factors for 
allergic rhinitis.  
Potential confounding variables were identified from those that showed a 
relation with allergic rhinitis in the univariate analysis. In the final model, we 
included those variables that changed the estimate of the odds ratio of the main 
exposure and allergic rhinitis in more than 10%.21  
Finally, based on the criteria mentioned above, 5 variables were kept in the final 
model: level of education, personal history of asthma, personal history of 
allergic dermatitis, family history of allergy and total fat intake.  
All analyses were performed using SPSS (Statistical Package for Social Sciences) 
version 18.0 and STATA, version 12, software.22,23 
3.2.2.7. Validation of the Outcome 
The main challenge of our diagnosis was to separate cases of allergic rhinitis 
from cases of non-allergic rhinitis as typical symptoms are often similar in both 
diseases. Furthermore, other diseases or syndromes such as common cold or 
sinusitis may also lead to erroneous diagnosis of allergic rhinitis as they cause 
nasal obstruction and block the sinuses.24,25  
Therefore, concurrently with the main study, we carried out a validation study 
aimed at documenting the validity of our diagnosis of allergic rhinitis. For this 
purpose, we used as a gold standard a sample of 255 persons randomly selected 
from our hospital subjects for whom the diagnosis of either allergic rhinitis, 
non-allergic rhinitis or no rhinitis was firmly established. Specifically, we 
selected 70 subjects whose diagnosis of allergic rhinitis was firmly established 
using a) clinical examination, b) positive skin prick tests (SPT) to common 
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inhaled allergens and/or presence of serum-specific IgE against these allergens 
and c) absence of previous medication against rhinitis. We further selected 25 
subjects with confirmed diagnosis of non-allergic rhinitis established after 
clinical examination, negative SPT and normal serum IgE level, and no use of 
any medication against rhinitis. Finally, we included 160 subjects who were 
confirmed as free of allergic and non-allergic rhinitis as well as of common cold 
and sinusitis. They had to fulfil the following criteria: 1) score of rhinitis 
symptoms ≤ 3 out of 12, (2) absence of any subjective feeling and diagnosis of 
rhinitis, (3) no use of any medication that could hide possible rhinitis 
symptoms. We asked those subjects to complete our disease questionnaire and 
we calculated the sensitivity and specificity of our diagnosis using different 
cutoff points for the symptom scores. The final figures were as follows for the 
diagnosis of allergic rhinitis: sensitivity 0.74 and specificity 0.92. These figures 
were reached using the cut-off point of allergic rhinitis symptoms score of 4 or 
more out of 12.  

3.2.3. RESULTS 
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3.2.3.1. Sample Description 
The final sample of this study consisted of 774 subjects: 387 cases and 387 age 
and sex-matched controls. The global response rate was 72.5%. Table 1 displays 
the distribution of the most important variables for cases and controls. Mean 
age of participants was 34.5 years and range from 18 to 77, with 129 (33%) men 
and 258 (67%) women in each group. The most important determinants 
associated with allergic rhinitis, in terms of odds ratio magnitude, which were 
introduced as variables of adjustment in the final model were level of 
education, comorbid asthma, comorbid dermatitis, allergy history in family 
members and total kilocalorie intake. Control subjects had higher education 
level (48%) compared with cases (33%). Comorbid asthma and comorbid 
dermatitis were much more frequent in cases (63% and 23% respectively) than 
in controls (4% and 4% respectively) and were significantly associated with the 
risk of allergic rhinitis risk (odds ratio (OR) = 41.6, 95% confidence interval (CI): 
17.13-101.00 for asthma and OR = 7.88, CI: 3.94-15.78 for dermatitis). Cases 
reported having family members with a history of allergic diseases such as 
rhinitis, asthma or dermatitis more frequently than the control group (60% of 
cases and 12% of controls). Moreover, allergic persons more often declared their 
residence of living in rural areas, while controls showed a higher proportion of 
smokers and alcohol drinkers. Overweight was more frequent among cases 
than among controls while levels of physical activity and energy expenditure 
were similar in both groups.  
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Table 1. Distribution of covariables for allergic rhinitis cases and controls 
Variable 
Cases (387) Controls (387) 
No. % No. % 
Sex           Male 129 33.3 129 33.3 
Age           18-30 164 42.4 164 42.4 
31-40 120 31.0 117 30.2 
41-50 66 17.1 67 17.3 
51-60 23 5.9 25 6.5 
61-80 14 3.6 14 3.6 
Education
No or Primary 111 29.4 70 19.0 
Secondary 143 37.9 121 32.8 
Higher 123 32.6 178 48.2 
History of Asthma 
No 144 37.2 328 95.6 
Yes 243 62.8 15 4.4 
History of Dermatitis 
No 299 77.3 329 95.9 
Yes 88 22.7 14 4.1 
Allergy history in family members
No 154 39.8 298 87.6 
Yes 233 60.2 42 12.4 
BMI 
<19 14 3.7 23 6.1 
19-25 206 53.8 226 59.5 
>25 163 42.6 131 34.5 
Energy expenditure in Kcal/h 
<9.75 71 22.2 71 20.8 
9.75-19.5 165 51.6 188 55.1 
>19.5 84 26.2 82 24.0 
Physical activity 
Low 54 17.4 82 23.6 
Light 170 54.7 166 47.8 
Moderate to Intense 87 28.0 99 28.5 
Smoking habits 
No smoking 276 71.9 248 64.8 
Former smoker 53 13.8 51 13.3 
Active/Occasional smoker 55 14.3 84 21.9 
Heating at home 
Do not have 51 13.8 29 9.2 
Butane 50 13.6 52 16.6 
Electrical 81 22.0 56 17.8 
Central 187 50.7 177 56.4 
Residency of living 
City 203 52.9 233 70.4 
Rural 181 47.1 98 29.6 
Alcohol consumption 
0 g/day 197 51.2 168 43.6 
1-4 g/day 62 16.1 51 13.2 
4-11 g/day 77 20.0 83 21.6 
>11 g/day 49 12.7 83 21.6 
Contact with animals 
No 174 45.1 178 51.9 
Little 66 17.1 28 8.2 
Frequent 33 8.5 82 23.9 
Daily 113 29.3 55 16.0 
Humidity at home 
No 278 72.6 243 75.7 
Yes 105 27.4 78 24.3 
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3.2.3.2. Dietary Patterns 
Protein consumption 
Association of allergic rhinitis and protein consumption, as well as other 
potential confounding and effect modifying variables is shown in table 2. A 
direct relation was observed between high protein consumption and allergic 
rhinitis (OR=3.79; 95% CI: 2.40-5.97 for the highest quartile of intake). The 
association was stronger after adjusting for confounders (OR=9.07; 95% CI: 1.92-
42.83 for the 4th quartile). 
Table 2. Odds ratios of allergic rhinitis by protein, energy and total fat intake 
Variable 
Cases Controls 
OR* 95% CI OR† 95% CI 
No. % No. % 
Protein intake 
(median g/day) 
1st quartile (72.25) 55 14.5 134 35.5 1.00 Reference 1.00 Reference
2nd quartile (93.89) 92 24.2 97 25.7 2.39 1.52-3.75 2.29 0.81-6.50
3rd quartile (118.31) 119 31.3 71 18.8 4.14 2.60-6.60 7.53 1.82-31.22
4th quartile (151.54) 114 30.0 75 19.9 3.79 2.40-5.97 9.07 1.92-42.83
Kcal intake  
(median Kcal/day) 
1st quartile (1557.64) 63 16.6 126 33.4 1.00 Reference 1.00 Reference
2nd quartile (1975.59) 103 27.1 86 22.8 2.35 1.53-3.60 1.72 0.64-4.66
3rd quartile (2400.46) 104 27.4 86 22.8 2.30 1.49-3.54 2.00 0.53-7.51
4th quartile (3071.00) 110 28.9 79 21.0 2.91 1.85-4.58 2.97 0.54-16.23
Total fat intake¥ 
(median g/day) 
1st quartile (55.72) 74 19.5 115 30.5 1.00 Reference 1.00 Reference
2nd quartile (74.26) 95 25.0 94 24.9 1.53 0.99-2.37 1.15 0.40-3.29
3rd quartile (89.65) 104 27.4 86 22.8 1.82 1.19-2.79 0.45 0.11-1.81
4th quartile (123.92) 107 28.2 82 21.8 1.94 1.27-2.97 0.29 0.06-1.44
* ORs were estimated from conditional logistic regression models, conditioned on age and sex
† OR’s of Protein and Kcal intake adjusted for education, history of asthma, history of dermatitis, allergy history in 
family members, and total fat intake (except for the variable of Total fat intake¥);  
¥OR’s of Total fat intake adjusted for education, history of asthma, history of dermatitis, allergy history in family 
members, and Protein intake. 
Our results show that thirty percent of our allergic rhinitis patients consume 
more than 134 grams of protein per day, while in the control group this figure 
was one-third lower (20%). After adjustment of potential confounders, subjects 
with high intakes of protein (third and fourth quartile) have a considerable 
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increase in the risk of allergic rhinitis. (Table 2) Assuming linearity of the effect 
we performed a logistic regression where intake of protein was introduced as a 
continuous variable. We found that every 10 g of protein augments the risk of 
allergic rhinitis by 10 percent (data not shown). 
Although the association is not statistically significant, energy intake is 
probably related to the risk of allergic rhinitis (OR for the 4th quartile = 2.97; 
95% CI: 0.54-16.23). Energy intake of a healthy and well-nourished population 
should maintain an adequate body mass index (BMI) at the population’s usual 
level of energy expenditure.26 According to WHO recommendations, energy 
requirements are specific to each person and vary with age, gender, body 
weight, physical activity level and basal metabolic rate, ranging from 1550 up to 
4500 Kcal/day.26 Mean daily Kcal intake of our control subgroup was 2181 
Kcal/day while that of cases was 2351 Kcal/day. 
The association of a high intake of proteins with increased risk of allergic 
rhinitis, persisted after adjustment for lifestyle variables such as physical 
activity, smoking habits or alcohol consumption, as well as after control of 
education level, history of asthma, history of dermatitis and allergy history in 
family members. Energy intake and total fat intake were clearly associated with 
protein consumption. However, adjustment for these variables did not mitigate 
the effect of protein consumption on the risk of allergic rhinitis, but, on the 
contrary, increased it. (Table 3) Our results showed a considerable increase in 
the risk of allergic rhinitis among subjects with high intakes of fish, meat, and 
dairy products. (Table 3) Proteins of animal origin seemed to exert higher effect 
than proteins of vegetable origin, although both showed increase in the effect 
for the highest quartile after total adjustment. (Table 3) 
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Table 3. Odds ratios of allergic rhinitis by selected food groups used in multivariate model introducing each food group one by one 
Variable Median (g/day) 
Cases Controls 
OR* 95% CI OR† 95% CI 
No. % No. % 
Fish and sea products 
1st quartile 51.51 81 21.3 108 28.6 1.00 Reference 1.00 Reference 
2nd quartile 82.41 74 19.5 116 30.7 0.94 0.62-1.41 1.16 0.45-2.99 
3rd quartile 121.90 115 30.3 75 19.8 2.12 1.38-3.26 2.20 0.75-6.45 
4th quartile 190.97 110 28.9 79 20.9 1.80 1.19-2.72 2.13 0.72-6.24 
Meat 
1st quartile 59.53 63 16.6 126 33.3 1.00 Reference 1.00 Reference 
2nd quartile 105.80 100 26.3 90 23.8 2.21 1.42-3.43 1.90 0.70-5.17 
3rd quartile 156.56 118 31.1 72 19.0 3.05 1.97-4.71 1.98 0.60-6.15 
4th quartile 215.85 99 26.1 90 23.8 2.08 1.35-3.20 0.94 0.29-3.08 
Dairy 
1st quartile 123.14 89 23.4 100 26.5 1.00 Reference 1.00 Reference 
2nd quartile 256.78 82 21.6 107 28.4 0.90 0.61-1.35 0.47 0.18-1.24 
3rd quartile 350.57 99 26.1 91 24.1 1.31 0.87-1.96 0.91 0.35-2.40 
4th quartile 623.76 110 28.9 79 21.0 1.70 1.12-2.59 0.82 0.26-2.57 
Eggs 
1st quartile 17.80 107 28.2 97 25.7 1.00 Reference 1.00 Reference 
2nd quartile 25.83 86 22.6 87 23.1 0.90 0.59-1.38 0.48 0.16-1.44 
3rd quartile 56.03 125 32.9 121 32.1 0.96 0.65-1.42 0.53 0.20-1.38 
4th quartile 77.48 62 16.3 72 19.1 0.77 0.49-1.21 0.79 0.23-2.73 
Proteins of Animal origin 
1st quartile 43.50 62 16.3 127 33.7 1.00 Reference 1.00 Reference 
2nd quartile 59.92 94 24.7 95 25.2 2.24 1.41-3.58 3.50 1.09-11.22 
3rd quartile 78.31 113 29.7 77 20.4 3.05 1.93-4.81 3.62 0.88-14.89 
4th quartile 105.90 111 29.2 78 20.7 2.93 1.87-4.59 7.66 1.35-43.38 
Proteins of Vegetable origin 
1st quartile 18.67 66 17.4 123 32.6 1.00 Reference 1.00 Reference 
2nd quartile 26.08 84 22.1 105 27.9 1.63 1.03-2.57 0.92 0.33-2.55 
3rd quartile 34.54 115 30.3 75 19.9 2.94 1.87-4.63 2.19 0.66-7.33 
4th quartile 47.48 115 30.3 74 19.6 3.36 2.09-5.38 4.60 1.02-20.83 
* ORs were estimated from conditional logistic regression models, conditioned on age and sex
†Adjusted for Kcal, education, history of asthma, history of dermatitis, allergy history in family members, and total 
fat intake. 
In general, high intakes of individual amino acids were related with increased 
risk of allergic rhinitis. (Table 4) Especifically, high intakes of leucine, tyrosine, 
valine and serine are associated with an increase in the risk of allergic rhinitis in 
a dose-response fashion. 
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Table 4. Odds ratios of allergic rhinitis and amino acids
Amino acid Median(g/day) 
Cases Controls 
OR* 95% CI OR† 95% CI 
No. % No. % 
Overall  387 387 
ESSENCIAL AMINO ACIDS 
Histidine
1st quartile 1.87 56 14.7 132 35.0 1.00 Reference 1.00 Reference
2nd quartile 2.47 92 24.2 98 26.0 2.32 1.48-3.62 2.65 0.90-7.79
3rd quartile 3.16 117 30.8 73 19.4 4.01 2.50-6.43 5.50 1.26-23.95
4th quartile 4.16 115 30.3 74 19.6 3.84 2.43-6.08 11.53 2.27-58.60
Isoleucine
1st quartile 3.33 64 16.8 125 33.2 1.00 Reference 1.00 Reference
2nd quartile 4.34 92 24.2 97 25.7 1.91 1.25-2.92 1.67 0.60-4.68
3rd quartile 5.45 109 28.7 81 21.5 2.63 1.70-4.07 4.05 1.02-16.09
4th quartile 7.15 115 30.3 74 19.6 3.11 2.01-4.81 8.86 1.86-42.32
Leucine
1st quartile 5.53 60 15.8 129 34.2 1.00 Reference 1.00 Reference
2nd quartile 7.26 85 22.4 104 27.6 1.86 1.20-2.86 2.04 0.73-5.73
3rd quartile 9.14 123 32.4 67 17.8 4.00 2.54-6.32 8.18 1.20-34.20
4th quartile 12.09 112 29.5 77 20.4 3.36 2.14-5.27 16.95 3.13-91.82
Lysine
1st quartile 4.70 56 14.7 133 35.3 1.00 Reference 1.00 Reference
2nd quartile 6.15 89 23.4 100 26.5 2.21 1.41-3.46 3.63 1.19-11.02
3rd quartile 7.92 121 31.8 69 18.3 4.31 2.69-6.91 6.95 1.72-28.02
4th quartile 10.63 114 30.0 75 19.9 3.89 2.44-6.20 11.69 2.36-57.90
Methionine
1st quartile 1.53 63 16.6 126 33.4 1.00 Reference 1.00 Reference
2nd quartile 2.03 86 22.6 103 27.3 1.69 1.09-2.61 1.80 0.65-4.98
3rd quartile 2.57 119 31.3 71 18.8 3.31 2.12-5.17 2.22 0.61-8.02
4th quartile 3.43 112 29.5 77 20.4 2.82 1.83-4.33 3.65 0.88-15.22
Phenylalanine
1st quartile 3.22 58 15.3 131 34.7 1.00 Reference 1.00 Reference
2nd quartile 4.14 87 22.9 102 27.1 2.11 1.34-3.34 1.76 0.61-5.08
3rd quartile 5.20 125 32.9 65 17.2 4.50 2.81-7.21 9.42 2.10-42.28
4th quartile 6.81 110 28.9 79 21.0 3.64 2.27-5.84 15.40 2.60-91.25
Threonine
1st quartile 2.71 57 15.0 132 35.0 1.00 Reference 1.00 Reference
2nd quartile 3.55 90 23.7 99 26.3 2.13 1.38-3.29 2.58 0.92-7.27
3rd quartile 4.49 121 31.8 69 18.3 4.01 2.53-6.36 7.03 1.74-28.37
4th quartile 5.97 112 29.5 77 20.4 3.44 2.18-5.41 7.07 1.58-31.55
Tryptophan
1st quartile 0.49 52 13.7 136 36.1 1.00 Reference 1.00 Reference
2nd quartile 0.66 101 26.6 89 23.6 2.91 1.83-4.61 1.86 0.62-5.55
3rd quartile 0.83 114 30.0 76 20.2 3.82 2.41-6.04 4.65 1.05-20.65
4th quartile 1.07 113 29.7 76 20.2 3.80 2.40-6.01 5.40 1.13-25.78
Valine
1st quartile 3.74 62 16.3 126 33.4 1.00 Reference 1.00 Reference
2nd quartile 4.89 83 21.8 107 28.4 1.73 1.12-2.67 2.01 0.70-5.80
3rd quartile 6.18 121 31.8 69 18.3 3.74 2.37-5.92 9.76 2.17-43.93
4th quartile 8.11 114 30.0 75 19.9 3.43 2.17-5.42 22.27 3.69-134.42
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Table 4. Cont. 
Amino acid Median(g/day) 
Cases Controls 
OR* 95% CI OR† 95% CI 
No. % No. % 
Overall  387 387
NONESSENTIAL AMINO ACIDS 
Alanine 
1st quartile 3.03 57 15.0 132 35.0 1.00 Reference 1.00 Reference
2nd quartile 3.96 86 22.6 103 27.3 2.03 1.30-3.16 3.46 1.17-10.21
3rd quartile 4.99 129 33.9 61 16.2 4.69 2.95-7.47 10.16 2.59-39.89
4th quartile 6.60 108 28.4 81 21.5 3.24 2.06-5.09 9.98 2.03-49.05
Arginine
1st quartile 3.63 52 13.7 137 36.3 1.00 Reference 1.00 Reference
2nd quartile 4.80 88 23.2 102 27.1 2.35 1.48-3.73 3.36 1.01-11.19
3rd quartile 6.11 131 34.5 58 15.4 5.89 3.62-9.59 27.53 5.13-147.67
4th quartile 8.08 109 28.7 80 21.2 3.79 2.36-6.09 12.77 2.45-66.69
Aspartic acid 
1st quartile 5.91 57 15.0 132 35.0 1.00 Reference 1.00 Reference
2nd quartile 7.77 85 22.4 104 27.6 1.99 1.28-3.08 2.85 0.97-8.38
3rd quartile 9.92 127 33.4 63 16.7 4.71 2.95-7.53 8.25 1.98-34.31
4th quartile 13.22 111 29.2 78 20.7 3.57 2.26-5.64 7.69 1.66-35.62
Cysteine
1st quartile 0.80 48 12.6 141 37.4 1.00 Reference 1.00 Reference
2nd quartile 1.05 103 27.1 86 22.8 3.34 2.10-5.31 3.80 1.26-11.47
3rd quartile 1.29 124 32.6 66 17.5 5.39 3.34-8.77 9.43 2.17-40.89
4th quartile 1.69 105 27.6 84 22.3 3.69 2.30-5.93 6.63 1.45-30.25
Glutamic acid 
1st quartile 12.54 58 15.3 131 34.7 1.00 Reference 1.00 Reference
2nd quartile 16.06 92 24.2 97 25.7 2.19 1.41-3.40 1.24 0.48-3.20
3rd quartile 20.12 116 30.5 74 19.6 3.43 2.19-5.38 4.55 1.34-15.46
4th quartile 26.32 114 30.0 75 19.9 3.62 2.30-5.70 5.00 1.06-23.53
Glycine
1st quartile 2.79 50 13.2 138 36.6 1.00 Reference 1.00 Reference
2nd quartile 3.69 99 26.1 91 24.1 3.10 1.93-4.99 2.67 0.92-7.74
3rd quartile 4.75 123 32.4 67 17.8 5.13 3.17-8.30 4.77 1.35-16.84
4th quartile 6.25 108 28.4 81 21.5 3.77 2.36-6.01 5.10 1.15-22.63
Proline
1st quartile 4.22 65 17.1 124 32.9 1.00 Reference 1.00 Reference
2nd quartile 5.57 85 22.4 104 27.6 1.59 1.03-2.45 1.61 0.61-4.24
3rd quartile 6.88 114 30.0 76 20.2 2.86 1.84-4.44 2.91 0.89-9.48
4th quartile 9.23 116 30.5 73 19.4 3.17 2.02-4.96 3.68 0.88-15.49
Serine
1st quartile 3.14 61 16.1 128 34.0 1.00 Reference 1.00 Reference
2nd quartile 4.11 85 22.4 105 27.9 1.76 1.14-2.73 2.75 0.85-8.87
3rd quartile 5.10 120 31.6 69 18.3 3.54 2.27-5.53 14.19 3.03-66.35
4th quartile 6.75 114 30.0 75 19.9 3.41 2.16-5.38 20.76 3.29-130.86
Tyrosine
1st quartile 2.37 64 16.8 125 33.2 1.00 Reference 1.00 Reference
2nd quartile 3.11 80 21.1 109 28.9 1.54 0.99-2.38 1.69 0.60-4.76
3rd quartile 3.94 118 31.1 72 19.1 3.49 2.20-5.52 12.08 2.49-58.56
4th quartile 5.24 118 31.1 71 18.8 3.59 2.26-5.71 28.54 4.42-184.33
* ORs were estimated from conditional logistic regression models, conditioned on age and sex
†Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, and total fat 
intake. 
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Dietary antioxidants 
We determined the daily intake of the following antioxidants: β-carotene, 
vitamin A, vitamin E, vitamin C, selenium and zinc. The association of allergic 
rhinitis with the intake of these antioxidants is shown in table 5. The strongest 
positive association for the highest quartile was observed for β-carotene 
(OR=5.12; 95% CI: 1.54-17.04). According to one pooled analysis of 500 000 
women living in the USA, Canada, and some European countries, the average 
daily intake of β-carotene should be in the range 2000-7000 µg.27  The mean 
intake of β-carotene in our study controls, that represent the general 
population, was 4839 µg/day, while that of cases was higher (6045 µg).  
High vitamin A consumption was related to an elevated risk of allergic rhinitis 
in crude analysis before adjusting (OR= 2.87; 95% CI: 1.82-4.52 for 4th quartile). 
After adjustment, the effect remained high for the 3rd quartile only.  
Vitamins E and C did not show any effect in the adjusted model while selenium 
and zinc, considered as antioxidants, showed a strong association, limited, 
however, to the 3rd quartile. (Table 5) 
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Table 5. Odds ratios of allergic rhinitis and antioxidants 
Variable Cases Controls OR* 95% CI OR† 95% CI
No. % No. % 
β-carotene intake  
(median µg/day) 
1st quartile (1480.89) 70 18.4 119 31.6 1.00 Reference 1.00 Reference 
2nd quartile (3178.22) 81 21.3 108 28.6 1.57 1.01-2.43 1.52 0.54-4.30 
3rd quartile (5849.28) 116 30.5 74 19.6 2.86 1.83-4.48 2.70 0.90-8.07 
4th quartile (9932.09) 113 29.7 76 20.2 3.14 1.95-5.04 5.12 1.54-17.04 
Vitamin A intake  
(median µg Eq/day) 
1st quartile (695.83) 65 17.1 124 32.9 1.00 Reference 1.00 Reference 
2nd quartile (1133.57) 88 23.2 101 26.8 1.79 1.14-2.81 1.08 0.42-2.80 
3rd quartile (1534.79) 119 31.3 71 18.8 3.17 2.04-4.92 4.10 1.26-13.41 
4th quartile (2261.91) 108 28.4 81 21.5 2.87 1.82-4.52 2.81 0.87-9.05 
Vitamin E intake  
(median mg/day) 
1st quartile (8.44) 68 17.9 121 32.1 1.00 Reference 1.00 Reference 
2nd quartile (11.51) 98 25.8 91 24.1 2.15 1.37-3.38 0.85 0.33-2.16 
3rd quartile (14.83) 111 29.2 79 21.0 2.98 1.86-4.77 1.22 0.41-3.65 
4th quartile (20.36) 103 27.1 86 22.8 2.43 1.53-3.86 2.09 0.57-7.73 
Vitamin C intake  
(median mg/day) 
1st quartile (110.73) 78 20.5 111 29.4 1.00 Reference 1.00 Reference 
2nd quartile (195.55) 79 20.8 110 29.2 1.01 0.66-1.56 0.82 0.30-2.21 
3rd quartile (280.94) 114 30.0 76 20.2 2.12 1.39-3.24 1.04 0.39-2.81 
4th quartile (425.12) 109 28.7 80 21.2 2.10 1.34-3.27 2.49 0.79-7.80 
Selenium intake 
(median µg/day) 
1st quartile (77.78) 57 15.0 132 35.0 1.00 Reference 1.00 Reference 
2nd quartile (103.18) 87 22.9 102 27.1 1.88 1.19-2.96 1.31 0.47-3.62 
3rd quartile (130.66) 127 33.4 63 16.7 4.67 2.91-7.50 6.27 1.67-23.49 
4th quartile (174.87) 109 28.7 80 21.2 3.24 2.04-5.14 3.96 0.90-17.31 
Zinc intake 
(median mg/day) 
1st quartile (12.16) 63 16.6 126 33.4 1.00 Reference 1.00 Reference 
2nd quartile (15.83) 88 23.2 101 26.8 1.74 1.12-2.70 2.36 0.77-7.19 
3rd quartile (19.04) 122 32.1 68 18.0 3.34 2.14-5.21 5.78 1.44-23.22 
4th quartile (24.08) 107 28.2 82 21.8 2.66 1.69-4.21 2.60 0.57-11.80 
Fruit intake 
(median g/day) 
1st quartile (75.06) 65 17.1 124 32.9 1.00 Reference 1.00 Reference 
2nd quartile (184.14) 92 24.2 97 25.7 1.88 1.20-2.94 1.70 0.62-4.62 
3rd quartile (306.88) 106 27.9 84 22.3 2.46 1.59-3.81 3.19 1.07-9.51 
4th quartile (519.93) 117 30.8 72 19.1 3.12 2.00-4.87 5.11 1.67-15.63 
Vegetable intake  
(median g/day) 
1st quartile (173.52) 68 17.9 121 32.1 1.00 Reference 1.00 Reference 
2nd quartile (312.23) 92 24.2 97 25.7 1.71 1.13-2.59 0.64 0.25-1.61 
3rd quartile (445.24) 107 28.2 83 22.0 2.42 1.57-3.73 1.43 0.56-3.66 
4th quartile (686.15) 113 29.7 76 20.2 3.11 1.95-4.96 2.51 0.83-7.58 
* Crude OR
† Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, and intake of 
Kcal/day.   
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Since fruits and vegetables are the main source of many antioxidants, they were 
also considered in this analysis as an important covariate. We introduced 
consumption of fruits and vegetables in to the crude and final adjusted analysis. 
The task was to verify if the effect of chosen vitamins and minerals with 
properties of antioxidant was actually attributable to that antioxidant or rather 
could be explained by the effect of the entire food group. Higher consumption 
of fruits showed a strong positive association before and after adjustment for 
confounding variables (OR=3.12; 95% CI: 2.00-4.87 and OR=5.11; 95% CI: 1.67-
15.63 for highest quartiles respectively). Consumption of vegetables was related 
with allergic rhinitis only in the crude analysis (OR=3.11; 95% CI: 1.95-4.96 for 
highest quartile), however this relation was not statistically significant after 
adjustment. (Table 5) 
Finally, we also carried out additional analyses introducing fruits and 
vegetables one by one as a confounding variable in to the final model 
established earlier. Results, which are displayed in table 6, show that 
consumption of β-carotene and fruit in general shows a strong effect on the 
development of allergic rhinitis. The effect of selenium and zinc has not 
changed substantially. 
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Table 6. Odds ratios of allergic rhinitis and antioxidants adjusting for 
 fruit and vegetable intake 
Variable OR* 95% CI OR† 95% CI 
β-carotene intake  
(median µg/day) 
1st quartile (1480.89) 1.00 Reference 1.00 Reference
2nd quartile (3178.22) 1.31 0.43-3.99 1.92 0.62-5.91 
3rd quartile (5849.28) 1.87 0.56-6.25 3.04 0.81-11.36 
4th quartile (9932.09) 3.83 1.06-13.80 4.51 0.84-24.25 
Vitamin A intake  
(median µg Eq/day) 
1st quartile (695.83) 1.00 Reference 1.00 Reference
2nd quartile (1133.57) 1.05 0.38-2.91 0.94 0.34-2.65 
3rd quartile (1534.79) 4.97 1.37-17.97 3.56 0.96-13.27 
4th quartile (2261.91) 2.44 0.73-8.12 1.15 0.24-5.53 
Vitamin E intake  
(median mg/day) 
1st quartile (8.44) 1.00 Reference 1.00 Reference
2nd quartile (11.51) 0.68 0.25-1.84 0.81 0.30-2.21 
3rd quartile (14.83) 0.78 0.23-2.57 0.98 0.31-3.14 
4th quartile (20.36) 1.23 0.28-5.40 1.29 0.27-6.19 
Vitamin C intake  
(median mg/day) 
1st quartile (110.73) 1.00 Reference 1.00 Reference
2nd quartile (195.55) 0.43 0.14-1.36 0.80 0.28-2.29 
3rd quartile (280.94) 0.36 0.10-1.31 0.63 0.19-2.11 
4th quartile (425.12) 0.79 0.19-3.21 1.33 0.33-5.29 
Selenium intake 
(median µg/day) 
1st quartile (77.78) 1.00 Reference 1.00 Reference
2nd quartile (103.18) 1.17 0.40-3.41 1.25 0.44-3.59 
3rd quartile (130.66) 5.86 1.41-24.32 5.06 1.29-19.89
4th quartile (174.87) 3.27 0.67-15.89 3.09 0.64-14.94 
Zinc intake 
(median mg/day) 
1st quartile (12.16) 1.00 Reference 1.00 Reference
2nd quartile (15.83) 2.14 0.66-6.95 2.27 0.69-7.46 
3rd quartile (19.04) 4.69 1.03-21.39 4.66 1.08-20.08
4th quartile (24.08) 2.06 0.40-10.70 1.54 0.30-7.87 
Fruit intake
(median g/day) 
1st quartile (75.06) --- --- 1.00 Reference 
2nd quartile (184.14) 1.47 0.52-4.15 
3rd quartile (306.88) 2.59 0.81-8.26 
4th quartile (519.93) 4.43 1.37-14.37 
Vegetable intake  
(median g/day) 
1st quartile (173.52) 1.00 Reference --- --- 
2nd quartile (312.23) 0.80 0.29-2.19 
3rd quartile (445.24) 1.36 0.50-3.69 
4th quartile (686.15) 2.50 0.79-7.96 
* Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, and
intake of Kcal/day and additionally for Fruit consumption in g/day.  
† Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, and 
intake of Kcal/day and additionally for Vegetables consumption in g/day. 
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Polyunsaturated fatty acids 
Association of allergic rhinitis and consumption of omega-3 and omega-6 
polyunsaturated fatty acids is displayed in table 7. Both types of 
polyunsaturated fatty acids were related with a tendency to decrease the risk of 
allergic rhinitis for the 4th quartile after adjustment, although this association 
was not statistically significant (OR=0.42; 95% CI: 0.13-1.38 for omega-3 and 
OR=0.55; 95% CI: 0.15-2.02 for omega-6). Forasmuch as main sources of omega-
3 fatty acids are fish and other sea products, and omega-6 mainly comes from 
vegetable oils, we also took into account these food groups in this analysis. 
Seafood as independent variable showed slight increment in risk after adjusting 
for confounding variables although the relation was not statistically significant 
(OR=2.24; 95% CI: 0.76-6.58 for the 4th quartile). (Table 7)  
Table 7. Odds ratios of allergic rhinitis and polyunsaturated fatty acids and seafood intake 
Variable Cases Controls OR* 95% CI OR† 95% CI 
No. % No. % 
Omega-3 intake 
(median g/day) 
1st quartile (2.28) 86 22.6 103 27.3 1.00 Reference 1.00 Reference 
2nd quartile (3.65) 94 24.7 95 25.2 1.24 0.82-1.88 1.17 0.47-2.91 
3rd quartile (4.78) 109 28.7 81 21.5 1.64 1.08-2.48 1.19 0.40-3.58 
4th quartile (7.82) 91 23.9 98 26.0 1.16 0.76-1.77 0.42 0.13-1.38 
Omega-6 intake 
(median g/day) 
1st quartile (7.61) 79 20.8 110 29.2 1.00 Reference 1.00 Reference 
2nd quartile (10.57) 97 25.5 92 24.4 1.52 1.00-2.29 0.99 0.37-2.65 
3rd quartile (13.99) 106 27.9 84 22.3 1.69 1.12-2.54 0.49 0.18-1.39 
4th quartile (18.84) 98 25.8 91 24.1 1.55 1.00-2.39 0.55 0.15-2.02 
Seafood intake 
(median g/day) 
1st quartile (51.51) 81 21.3 108 28.6 1.00 Reference 1.00 Reference 
2nd quartile (82.41) 74 19.5 116 30.7 0.94 0.62-1.41 1.27 0.52-3.14 
3rd quartile (121.90) 115 30.3 75 19.8 2.12 1.38-3.26 2.17 0.77-6.14 
4th quartile (190.97) 110 28.9 79 20.9 1.80 1.19-2.72 2.24 0.76-6.58 
Oil intake 
(median g/day) 
1st quartile (0.50) 84 22.1 105 27.8 1.00 Reference 1.00 Reference 
2nd quartile (0.86) 123 32.4 81 21.4 1.90 1.25-2.88 3.75 1.38-10.18 
3rd quartile (1.22) 81 21.3 76 20.1 1.33 0.86-2.06 0.71 0.26-1.96 
4th quartile (1.79) 92 24.2 116 30.7 1.01 0.67-1.52 0.90 0.34-2.43 
* Crude OR
† Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, and intake 
of Kcal/day.   
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So as to ascertain that consumption of seafood and oil did not interact with the 
effect of polyunsaturated fatty acids, they were introduced in the final adjusted 
analysis. (Table 8) The results did not change substantially. One can observe, 
however, a statistically non-significant effect of omega-6 that follows a dose-
response pattern. (Table 8) 
Table 8. Odds ratios of allergic rhinitis and omega-3 and omega-6 polyunsaturated fatty acids additionally adjusting for seafood and oil intake 
Variable OR* 95% CI OR† 95% CI 
Omega-3 intake  
(median g/day) 
1st quartile (2.28) 1.00 Reference 1.00 Reference
2nd quartile (3.65) 1.10 0.43-2.78 1.42 0.54-3.78 
3rd quartile (4.78) 1.03 0.33-3.21 1.26 0.38-4.20 
4th quartile (7.82) 0.39 0.11-1.33 0.43 0.12-1.61 
Omega-6 intake 
(median g/day) 
1st quartile (7.61) 1.00 Reference 1.00 Reference
2nd quartile (10.57) 0.80 0.28-2.27 0.70 0.24-2.02 
3rd quartile (13.99) 0.39 0.13-1.18 0.47 0.15-1.46 
4th quartile (18.84) 0.35 0.09-1.48 0.42 0.10-1.80 
* Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, intake of
Kcal/day and additionally for seafood intake 
† Adjusted for education, history of asthma, history of dermatitis, allergy history in family members, intake of
Kcal/day and additionally for oil intake  

3.2.4. DISCUSSION 
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The findings from this study provide strong evidence that a high intake of 
proteins is associated with increased risk of allergic rhinitis.  
This association persisted after adjustment of lifestyle variables such as physical 
activity, smoking habits or alcohol consumption, as well as after control of 
education level, history of asthma, history of dermatitis and allergy history in 
family members. Energy intake and total fat intake were clearly associated with 
protein consumption. However, adjustment for these variables did not mitigate 
the effect of protein consumption on the risk of allergic rhinitis, but, on the 
contrary, increased it. Other variables that we did not measure in our study, or 
for which results are not available yet, may play the role of effect modifiers or 
confounders. These unmeasured variables include genetic factors, some of 
which were recently implicated in the etiology of the disease.1  
As in any case-control study, memory and recall bias is a concern in our study. 
Differential recall between cases and controls would certainly introduce bias. 
However, in the present study, differential reporting, which leads cases to 
overestimate their protein, fruit, seafood or other nutrient intake, and controls 
to underestimate it, is unlikely as the questionnaire does not state the research 
question but only assesses food items and dishes. Measurement error in the 
assessment of these nutrients and food groups is likely to occur, but it is 
probably non differential with respect to disease status. If this bias exists, our 
results would then be biased towards the null value and our results would the 
underestimate the true effect.   
Furthermore, despite the relatively high figures of sensitivity and specificity of 
our diagnosis of allergic rhinitis, misclassification of the outcome cannot be 
ruled out as symptoms of rhinitis are often mistaken with upper respiratory 
tract infections such as common cold or sinusitis.6,7,24 However, this potential 
misclassification is unlikely to be differential with respect to exposure, and, 
again, our results would the underestimate the true effect. 
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Few studies related protein intake with the risk of allergic rhinitis. An 
ecological analysis of the International Study of Asthma and Allergies in 
Childhood (ISAAC) revealed a protective effect of high intakes of protein from 
cereal and nuts on allergic rhino-conjunctivitis. However, this study did not 
suggest any explanatory model and the association observed may be spurious.28 
Possible explanations for the harmful effect of high intakes of protein may be 
advanced. Since the proportion of total energy, derived from protein, is 
relatively constant, protein intake may be considered as an indicator of total 
energy intake.2 The risk increase among subjects with high intake of protein 
may then be mediated by the effect of energy intake. Our results show that a 
high energy intake is a risk factor of allergic rhinitis. Previous studies showed 
that caloric and protein restriction may boost cell-mediated immunity and 
antioxidant defenses, which inhibits oxidative damage and inflammation.287 
Excessive intake of protein and/or energy may then produce the opposite 
effect. 
Other studies showed that low body mass, which could be conceptualized as a 
proxy for low energy intake, was associated with lower prevalence of atopic 
diseases such as asthma, while high energy intake was significantly associated 
with asthma.30,31 Furthermore, other studies showed that obesity and 
overweight could be related to respiratory allergy through the inflammatory 
pathway, essentially through the increase of immune activity caused by 
adipokines, a specific type of cytokines secreted by adipose tissue.32,33 Other 
cytokines, such as interleukin 10 (IL-10) and interferon gamma (IFN-γ) were 
also associated with excessive body weight and excessive consumption of 
nutrients.34 It is remarkable that malnutrition was found to decrease the ability 
to produce cytokines.35,36 
Other plausible explanations include the fact that a considerable proportion of 
the protein intake is due to meat products, which were associated with 
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increased inflammation status and increased risk of hay fever and asthma in 
previous studies.37,38 
Furthermore, high amounts of protein are often associated with high quantities 
of sodium chloride, present in processed meat products. High levels of protein 
and sodium chloride in the diet increase the acidity of the blood and tissues.39,40 
Long-term metabolic acidosis consequences include systemic inflammation and 
impairment of the immune response.40-42 
Finally, high intakes of protein are frequently associated with meat cooked at 
high temperatures. This kind of meat may contain high amounts of mutagens, 
such as polycyclic aromatic hydrocarbons and heterocyclic amines, formed 
during high-temperature cooking and grilling. Some of these mutagens were 
linked to respiratory disorders such as asthma,37,43 as they interfere with 
membrane-bound β(2)-adrenergic receptors in the respiratory epithelium and 
trigger asthma attacks in asthmatics.43 Allergic rhinitis and asthma share a 
common pathophysiology and similar risk factors and environmental triggers. 
Some authors think that both conditions are likely to be manifestations of the 
same systemic inflammatory disease as they often co-exist in the same patient 
and can predict the appearance of each other.44-46 
The risk of allergic rhinitis increased with higher intake of most dietary 
antioxidants in our study population. Every antioxidant, including vitamin 
antioxidants which are obtained from food, is a redox (reduction-oxidation) 
agent, protecting against free radicals in some circumstances, but acting also as 
prooxidant and promoter of free radical under other conditions.47 It was stated 
that excessive antioxidant action can adversely affect key physiological 
processes.48 For example, large doses of vitamin E increase immune activity and 
may promote progression of immune and autoimmune diseases like asthma 
and allergies.49 Furthermore, vitamin C is reported to have prooxidant 
properties in the presence of high body iron stores.47 
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Fruits and vegetables are the main source of antioxidants. While several studies 
found no effect of fruit on allergic rhinitis,30,50-52 one study confirmed our results 
that show that a high or excessive intake of fruit could be a risk factor for 
allergic rhinitis.37 Many fruits and vegetables contain high amounts of 
histamine and other biogenic amines that may produce symptoms such as 
sneezing, congestion and rhinorrhea.37 These amines could then act as possible 
confounders of the relation fruit intake-allergic rhinitis.
 Several studies confirm our results showing that β-carotene may be a risk 
factor for allergic rhinitis.50,52 Under specific circumstances, including presence 
of other antioxidants, such as vitamins E and C and other carotenoids, β-
carotene may shift its antioxidant activity into prooxidant.48,53 
The mechanism of ‘‘anti-oxidative stress’’ was also used recently to explain 
possible adverse effects of antioxidants.54 This theory is based on the fact, that 
the susceptibility for allergic diseases may not only increase when Th2-type 
cytokines are over-produced but also when Th1-type cytokines, such as 
Interferon-c, are suppressed. High intakes of food rich in antioxidants may 
decrease Th1-type immunity and promote Th2-type immunity, which increases 
the susceptibility to allergic diseases when an allergen is incorporated.54 The 
activation of the Th2-type immunity increases the production of specific IgE 
antibodies. These antibodies circulate in the peripheral blood and attach on the 
surface of all mast cells and basophils, including those of the nasal mucosa, thus 
producing acute nasal symptoms.55,56 
In summary, an excessive intake of ‘‘healthy food’’ rich in antioxidants could 
increase the susceptibility to allergy via the anti-oxidative stress pathway. 
However, the most plausible explanation of our surprising result is reverse 
causality. Subjects with allergic rhinitis may increase their intake of fruit in 
order to promote general health and boost immunity. Theoretically, this should 
not occur in a case-control study with incident cases as ours, since exposure 
assessment precedes disease occurrence. However, we should bear in mind that 
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our cases may have been suffering from allergic rhinitis for a long period 
without being diagnosed and even without having sought medical advice. They 
may then have changed their diet pattern after the onset of disturbing 
symptoms. 
In our study, high intakes of omega-3 and omega-6 polyunsaturated fatty acids 
were related with a tendency to decrease the risk of allergic rhinitis, although 
the association observed was not statistically significant. Polyunsaturated fatty 
acids are essential in ensuring the correct environment for membrane protein 
function, maintaining membrane fluidity and regulating cell signaling, gene 
expression and cellular function. It was suggested that through these actions 
polyunsaturated fatty acids can influence the functioning of immune cells and 
so, could have an impact on the development and manifestations of atopic 
diseases.57 However, the information available on the role of each of the 
polyunsaturated fatty acids on the immune system is controversial.  
While several studies have linked omega-6 polyunsaturated fatty acids with 
increased risk of allergic rhinitis,58-63 and other studies have failed to find any 
relationship,31,64-67 two studies confirmed our results that higher intake of 
omega-6 protects from allergic rhinitis.50,68 
One the one hand, it is known that omega-6 polyunsaturated fatty acids 
participate in the production of prostaglandin E2, which shifts the Th1/Th2 
balance in to the Th2 direction, a mechanism that favors, as we saw before, Th2-
determined diseases such as allergies.50 On the other hand, higher production of 
prostaglandins E2 was shown to inhibit allergen-induced inflammatory 
responses, which may then decrease the risk of allergic conditions such as 
rhinitis.68 Biologically, both risk and prevention actions of omega-6 
polyunsaturated fatty acids are then plausible. 
The role of omega-3 polyunsaturated fatty acids is more straightforward. They 
were reported to decrease the production of inflammatory mediators and 
increase the level of anti-inflammatory mediators.69 Dietary omega-3 
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polyunsaturated fatty acids decrease the level of arachidonic acid and increase 
eicosapentaenoic acid, which suppresses eicosanoids such as prostaglandin E2, 
a molecule associated with systemic inflammatory response as we saw before. 
This suppression yields to production of less biologically active 3-series 
prostaglandins (PG) and 5-series leukotrienes (LT), which decrease allergic 
reaction.50,70 Also it was reported that omega-3 can alter gene expression, 
decreasing transcription factor activity such as nuclear factor-kB (NF-kB), which 
plays a role in activating inflammatory genes.71 
Furthermore, omega-3 polyunsaturated fatty acids are reported to inhibit T-cell 
proliferation and production of IL-2 and IFNg, which are Th1-type cytokines. 
As mentioned before, this increases the susceptibility to allergic diseases.72
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Annex I (side A). Data collection questionnaire. 
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Annex I (side B). Data collection questionnaire. 
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Annex I (side C). Data collection questionnaire. 
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Annex I (side D). Data collection questionnaire. 
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Antihistamines Corticosteroids AR  
AR & 
Asthma Asthma noAR 
Aerius 
Afluón 
Alastina 
Alercina 
Alergoflat 
Alergoliber 
Alerlisin 
Alerrid 
Alersol 
Atarax 
Azaron 
Azomyr 
Bactil 
Benadryl 
Bilaxten 
Bilina 
Biodramina 
Cetimerck 
Cetineu 
Cetirizina EFG 
Chiclida 
Cinfamar 
Clarytine 
Cliveran 
Cobiona 
Corifina 
Coulergin 
Dormidina 
Dramine 
Ebastel 
Ebastina EFG 
Fenergan 
Fenistil 
Fexofenadina 
EFG 
Fluidasal 
Frinova 
Ibis 
Ketasma 
Klarvitina 
Livocab 
Loratidina EFG 
Mircol 
Mizolen 
Muntel 
Navicalm 
Obalix 
Olopatanol 
(colirio) 
Oxatokey 
Periactin 
Polaramine 
Ratioalerg 
Reactine 
Relestat (colirio) 
Rinialer 
Rupafin 
Soñodor 
Stopcold Virtlix 
Tavegil 
Telfast 
Variargil 
Velodan 
Viternum 
Xazal 
Zaditen 
Zasten 
Zolistan 
Zyrtec 
Acetato de 
cortisona 
Beclometasona 
Betametasona 
Budesonida 
Clobetasol 
Clobetasona 
Desoximetasona 
Dexametasona 
Diclorisona 
Diflorasona 
Diflucortolona 
Fluclorolona 
Flumetasona 
Fluocinolona 
Fluocinónido 
Fluocortina 
Flupamesona 
Fluticasona 
Halcinónido 
Halometasona 
Hidrocortisona 
Metilprednisolona 
Metilprednisona 
Mometasona 
Prednicarbato 
Prednisolona 
Prednisona 
Triamcinolona 
Aerius 
Afluon 
Colyrio 
Alergoliber 
Atrovent nasal 
Avamys 
Azomyr 
Bilina 
Budesonida 
nasal 
Clarityne 
Ebastina 
Evastel 
Flixonase 
Grazax 
(vacuna) 
Levocetirizina 
Loratadina 
Mizolen 
Mometasona 
Muntel 
Nasacort 
Nasonex 
Rhinocort 
Rhinomer 
Rhinomer 
Rhinospray 
Rinelon 
Rinocorin 
Rino-Ebastel 
Rupafin 
Singulair 
Talforte 
(vacuna) 
Xazal 
Dimetane 
Chlor-
Trimeton 
Tavist  
Benadryl 
Claritin 
Zyrtec 
Optimine 
Allegra 
Atarax  
Vistaril 
Cetirizina 
Dezacor 
Flixonase 
Idasal 
Respibien 
Rinobactil 
Telfast 
Vispring 
colirio 
Zasten 
Alvesco 
Anasma 
Atrovent 
Budesonida 
Dacortin 
Foradil 
Formodual 
Formoterol 
Foster 
Inaladuo 
Pectox Lisina 
Plusvent 
Pulmicort 
Ribujet 
Rilast 
Salbutamol 
Seretide 
Symbicort 
forte 
Terbasmin 
Terbutalina 
Urbason 
Ventolin 
Atrovent 
nasal 
Avamys 
Budesonida 
nasal 
Flixonase 
Idasal 
Rino-
Ebastel 
AR – allergic rhinitis 
noAR – non-allergic rhinitis 
Annex II. List of medicines commonly used for treating symptoms of allergic 
rhinitis, non-allergic rhinitis and asthma.  
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Annex III. Informed consent model used 


4. GENERAL CONCLUSIONS
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1. In our meta-analysis, there is evidence of a weak association between
exposure to tobacco smoke and allergic rhinitis among adults.
2. Among children and adolescents, both active and passive exposure to
tobacco smoking are associated with a moderate increase of the risk of
allergic rhinitis.
3. The findings of the prospective case control study provide strong
evidence that a high intake of proteins is associated with increased risk
of allergic rhinitis.
4. Proteins of animal origin exert a stronger effect on allergic rhinitis than
proteins of vegetable origin.
5. High intakes of the amino acids leucine, tyrosine, valine and serine are
associated with an increase in the risk of allergic rhinitis in a dose-
response fashion.
6. High intakes of β-carotene increase the risk of developing allergic
rhinitis.
7. High consumption of fruits shows strong positive association with
allergic rhinitis, while that of vegetables is weakly associated with this
disease. However, these associations may be due to reverse causality.
8. High intakes of omega-3 and omega-6 polyunsaturated fatty acids showe
a tendency to decrease the risk of allergic rhinitis.

5. RESUMEN DE LA TESIS
DOCTORAL  

Jurgita Saulyte Resumen  
Estudios epidemiológicos de los factores de riesgo de la rinitis alérgica 259
La rinitis alérgica se describe como la inflamación de la membrana de la mucosa 
nasal, mediada por la producción de inmunoglobulina-E (IgE). Normalmente se 
presenta con secreción nasal, obstrucción y picor nasal y estornudos. Los 
síntomas son reversibles y están provocados por la exposición a alérgenos u 
otros factores ambientales de presencia continua o estacional, por  lo que la 
rinitis alérgica se clasifica en estacional o perenne. Últimamente también se ha 
propuesto una clasificación nueva según la gravedad y duración de los 
síntomas: rinitis alérgica intermitente o persistente. 
La rinitis alérgica es una de las enfermedades alérgicas con mayor prevalencia 
que, por su elevada incidencia, impacto sustancial en la calidad de vida y alto 
coste económico, tiene una importancia que se ha infravalorado hasta ahora en 
la investigación epidemiológica. Se ha estimado que la rinitis alérgica afecta a 
más de 600 millones de personas en todo el mundo y esta cifra sigue 
incrementándose, especialmente en los países más desarrollados. Dado que esta 
enfermedad a menudo puede ser trivializada por el paciente o no reconocida 
por el médico, produciéndose, así, un control inadecuado de los síntomas, esta 
cifra, probablemente, subestima la verdadera magnitud de la enfermedad lo 
que la convierte en un problema de Salud Pública importante en este siglo. 
Según la literatura más reciente, las interacciones genético-ambientales son los 
factores de riesgo más importantes de las enfermedades atópicas tales como la 
rinitis alérgica. Así mismo, la causa más plausible del aumento de la 
prevalencia en las últimas décadas puede estar relacionada con los cambios en 
los factores de riesgo asociados con el medio ambiente y el estilo de vida: la 
dieta, el estrés, la contaminación, las vacunas y los patrones de infección en la 
infancia. La “hipótesis de la higiene”, asociada con la considerable mejoría del 
saneamiento, está ganando credibilidad. Esta teoría afirma que la exposición 
temprana a los agentes infecciosos influye en el desarrollo del sistema 
inmunológico reduciendo la probabilidad de desarrollar enfermedades 
atópicas, mientras un exceso de higiene aumenta la probabilidad de desarrollar 
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las enfermedades tales como la rinitis alérgica y el asma más adelante en la vida 
del niño. 
Los hábitos de estilo de vida son unos de los pocos factores que se pueden 
manipular con el fin de prevenir una enfermedad. La nutrición es uno de los 
componentes más importantes entre los que tienen una influencia considerable 
en la salud de los seres humanos. 
La identificación de los factores modificables de la rinitis alérgica tiene 
implicaciones importantes en la calidad de vida de los pacientes, así como en la 
reducción de los gastos directos e indirectos de esta enfermedad. Los cambios 
de estilo de vida, tales como el hábito dietético y el hábito de fumar, pueden ser 
unos de los factores esenciales y por ello hemos decidido llevar a cabo un 
metaanálisis y un estudio de casos y controles con los siguientes objetivos: 
1. Determinar el efecto de consumo de tabaco sobre el desarrollo de rinitis
alérgica según los estudios realizados: realizar una revisión sistemática y un 
metaanálisis de los artículos publicados hasta el momento acerca de los hábitos 
de fumar y riesgo de rinitis alérgica. 
2. Determinar el efecto del consumo alto de la proteína en la dieta diaria sobre
el desarrollo de la rinitis alérgica. 
3. Determinar el efecto del consumo alto de los antioxidantes: ß-caroteno,
vitamina A, vitamina E, vitamina C, selenio y zinc en la dieta diaria sobre el 
desarrollo de la rinitis alérgica. 
4. Determinar el efecto del consumo alto de los ácidos grasos poliinsaturados
omega-3 y omega-6 en la dieta diaria sobre el desarrollo de la rinitis alérgica. 
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El tabaquismo es uno de los factores potenciales para las enfermedades atópicas 
como la rinitis alérgica, pero hasta ahora los resultados de los estudios 
individuales han sido contradictorios. El objetivo del metaanálisis que hemos 
realizado fue examinar las evidencias de las asociaciones entre el hábito de 
fumar activo o la exposición pasiva al humo de tabaco y la rinitis alérgica. 
Para ello, hemos recuperado los estudios publicados en cualquier idioma hasta 
el 30 de junio de 2013 mediante la búsqueda sistemática en Medline, Embase, 
las cinco bases de datos bibliográficas regionales de la Organización Mundial de 
la Salud y las bases de datos ISI-Proceedings; examinando manualmente las 
referencias de los artículos originales y de las revisiones recuperadas, y 
mediante el establecimiento de contacto personal con investigadores clínicos. 
Hemos incluido estudios de cohortes, de casos y controles, y transversales que 
presentaban estimaciones de odds ratio (OR) o riesgos relativos (RR) así como 
intervalos de confianza para los hábitos de fumar y rinitis alérgica,  primero 
entre la población general y luego entre los niños. 
Para calcular los riesgos relativos agrupados, con sus intervalos de confianza de 
95%, hemos ponderado los odds ratios de los estudios transversales y de casos 
y controles, y los riesgos relativos de los estudios de cohortes, ponderándolos 
por el inverso de su varianza. Para cada estudio, se utilizó la estimación de la 
medida de efecto que se ajustó por el mayor número de factores de confusión. 
Cuando había heterogeneidad se utilizó el modelo de efectos aleatorios, y 
cuando esta estaba ausente, el modelo de efectos fijos.  
Para comprobar la heterogeneidad, hemos utilizado una versión de la prueba 
de DerSimonian y Laird Q, adaptada a muestras pequeñas. La hipótesis nula 
de esta prueba es la ausencia de la heterogeneidad. Para cuantificar esta 
heterogeneidad se calculó la proporción de la varianza total debida a variación 
entre estudios (estadístico Ri). Además, hemos explorado el origen de la 
heterogeneidad estratificando nuestro análisis según varias variables tales 
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como diseño, tipo de exposición (tabaquismo activo o pasivo) y edad de los 
participantes (niños/adolescentes o adultos).  
Se evaluó el sesgo de la publicación visualmente, utilizando los gráficos en 
embudo, y después, más formalmente, mediante el test de Egger. Todos los 
análisis se realizaron con el software HEpiMA® versión 2.1.3 Y STATA versión 
12. 
Hemos conseguido 97 estudios de rinitis alérgica y hábitos de fumar que 
sirvieron para ser incluidos en nuestro metaanálisis. Al analizar todos los 
estudios juntos la rinitis alérgica no se asoció con el tabaquismo activo (RR 
agrupado, 1.02; 95% CI: 0.92–1.15), pero se asoció con el tabaquismo pasivo (RR 
agrupado 1.10; 95% CI: 1.06–1.15). Entre los niños y adolescentes, tanto el 
tabaquismo activo como pasivo se asociaron con un aumento moderado del 
riesgo de la rinitis alérgica: para los fumadores activos el RR agrupado fue 1.40; 
95% CI: 1.24–1.59 y para los fumadores pasivos el RR agrupado fue 1.09; 95% 
CI: 1.04–1.14. Las asociaciones del tabaquismo y la rinitis alérgica en los adultos 
fueron muy moderadas.  
Se han observado asociaciones modestas entre el tabaquismo y la rinitis alérgica 
en los adultos. Los resultados están limitados por el potencial de la confusión y 
el sesgo dado que la mayoría de los estudios utilizó un diseño transversal. 
Además, los estudios mostraron un alto grado de heterogeneidad y las medidas 
de la exposición y la enfermedad se evaluaron bajo auto-informe, lo que puede 
incrementar la posibilidad de errores de clasificación. 
Los presentes hallazgos sugieren que, en los países donde fuman muchas 
personas, el 14% de la rinitis alérgica en los niños puede ser atribuible al 
tabaquismo activo. Por lo tanto, la eliminación del tabaquismo activo entre los 
niños y adolescentes podría prevenir uno de cada siete casos de rinitis alérgica. 
La segunda parte de nuestro trabajo consistía en realizar un estudio de casos y 
controles para determinar el efecto del consumo alto de proteína, antioxidantes 
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y ácidos grasos poliinsaturados en la dieta sobre el desarrollo de la rinitis 
alérgica. 
Con el propósito de encontrar los factores de riesgo dietéticos de la rinitis 
alérgica, hemos llevado a cabo un estudio de casos y controles entre enero de 
2011 y octubre 2013. Se incorporaron 387 casos y 387 controles de 6 farmacias en 
2 ciudades del noroeste de España y de las unidades de neumología, 
alergología y de urgencias de 2 hospitales principales de las mismas ciudades: 
Santiago de Compostela y Pontevedra. En cada ubicación (farmacia o unidad 
hospitalaria), los controles fueron emparejados por edad y sexo.  
La participación en el estudio fue voluntaria y anónima, informando del estudio 
que se estaba llevando a cabo y ofreciendo la participación en él. Dicha 
participación consistió en la cumplimentación de un cuestionario de 4 páginas, 
a partir de cuyas preguntas se conformaron las variables de exposición y de 
enfermedad, referentes al año anterior a la fecha de la encuesta. El cuestionario 
consistió en una serie de preguntas sobre síntomas de rinitis, antecedentes 
médicos, frecuencia de consumo de alimentos (Food Frequency Questionnaire 
(FFQ)) y preguntas sobre otras variables de estilo de vida que podrían ser 
posibles factores de confusión de la relación entre la dieta y la rinitis alérgica. 
Previamente, los participantes firmaban un documento mediante el cual 
otorgaban su consentimiento a participar en el estudio admitiendo que habían 
sido informados de sus características.   
Para determinar los casos de rinitis alérgica, hemos utilizado el cuestionario 
elaborado por “The Allergic Rhinitis and its Impact on Asthma” (ARIA), junto 
con los criterios propuestos por “The Joint Task Force on Practice Parameters”. 
Se pidió a los participantes que registrasen la presencia habitual de seis 
síntomas principales de la rinitis en los días más severos, evaluando su 
frecuencia de 0 (ningún ataque en el día) a 4 (más de 20 ataques en el día). Estos 
síntomas fueron: nariz taponada, estornudos, secreción nasal, secreción 
postnasal, picazón de la nariz y picazón de los ojos u ojos llorosos. También se 
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les pedía evaluar la consistencia de la secreción nasal, de 0 (muy acuosa) a 4 
(muy espesa), y el color, de 0 (incolora) a 4 (verde). 
El desafío principal de nuestro diagnóstico era separar los casos de rinitis 
alérgica de los casos de rinitis no alérgica, ya que los síntomas típicos suelen ser 
similares en ambas enfermedades. Además, otras enfermedades tales como el 
catarro común o la sinusitis también pueden llevar a un diagnóstico erróneo de 
rinitis alérgica ya que provocan obstrucción nasal y bloquean los senos 
paranasales. Por lo tanto, al mismo tiempo que el estudio principal, se realizó 
un estudio de validación destinado a documentar la validez de nuestro 
diagnóstico de la rinitis alérgica. Para ello, se utilizó como estándar de oro una 
muestra de 255 personas seleccionadas al azar entre nuestros sujetos 
hospitalarios que previamente habían sido diagnosticados de rinitis alérgica, de 
rinitis no alérgica y de los en que se confirmó la ausencia de rinitis. Más 
precisamente, hemos seleccionado 70 pacientes con el diagnóstico de rinitis 
alérgica confirmado por a) examen clínico, b) pruebas cutáneas positivas a los 
alérgenos inhalados comunes y/o presencia de IgE específicas en el suero c) 
ausencia de medicación previa de rinitis. También, hemos seleccionado 25 
sujetos con diagnóstico confirmado de la rinitis no alérgica, que fue establecido 
por examen clínico y confirmado por pruebas cutáneas negativas y niveles de 
IgE en suero normales. Los sujetos con rinitis no alérgica también tenían que 
confirmar que no habían tomado ningún tipo de medicación para los síntomas 
de rinitis durante el último año. Por último, se incluyeron 160 sujetos que 
fueron confirmados como libres de rinitis alérgica y no alérgica, así como de 
cátaro común y sinusitis. Estos sujetos tenían que cumplir los siguientes 
criterios: 1) puntuación de síntomas de rinitis ≤ 3 sobre 12, (2) ausencia de 
cualquier sospecha subjetiva y de diagnóstico confirmado previamente de 
rinitis, (3) no estar tomando ningún medicamento que podría ocultar posibles 
síntomas de rinitis. Se les pidió a estos sujetos completar nuestro cuestionario 
de enfermedad y se calculó la sensibilidad y especificidad de nuestro 
diagnóstico, utilizando diferentes puntos de corte para las puntuaciones de los 
síntomas. Las cifras finales para el diagnóstico de rinitis alérgica fueron las 
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siguientes: sensibilidad 0.74 y especificidad 0.92. Estas cifras se alcanzaron 
utilizando el corte de 4 puntos o más sobre 12 en la puntuación total de 
síntomas.  
Después de la validación de caso, hemos establecido cuatro criterios que fueron 
necesarios para el diagnóstico de la rinitis alérgica mediante nuestro 
cuestionario: (1) puntuación mínima de 4 sobre 12 puntos en la puntuación total 
de los tres síntomas principales de rinitis (nariz taponada, estornudos y 
secreción por la nariz), (2) consistencia de la secreción nasal muy acuosa, acuosa 
o media, (3) color de la secreción nasal incolora o blanca, y (4) por lo menos uno
de los alérgenos que provocan las síntomas de la rinitis tenía que ser polen, 
polvo doméstico o pelo de animales.  
Para evaluar el consumo diario de los macro y micronutrientes, junto con el 
consumo diario de energía de la dieta regular y obtener la ingesta diaria de 
macro y micronutrientes, se utilizó un cuestionario de frecuencia alimentaria de 
86 ítems elaborado a partir de un cuestionario de frecuencia alimentaria (FFQ) 
validado en España. A los participantes se les pidió que indicasen la frecuencia 
media de consumo de cada uno de los alimentos en porciones o unidades al día 
o a la semana durante el último año. El consumo de cada alimento fue
recodificado en una escala con un rango de 8 categorías: de "nunca" a "más de 
tres veces al día."  
Para calcular el contenido de macro y micronutrientes para cada alimento se 
utilizó la Base de Datos de Composición de Alimentos Española, ampliada con 
fuentes europeas y estadounidenses cuando algunos datos no estaban 
disponibles en las fuentes españolas. 
La variable de ingesta diaria de proteínas fue creada calculando el contenido 
real de la proteína en cada uno de los alimentos del cuestionario. La misma 
metodología se aplicó para el cálculo de la ingesta diaria de otros macro y 
micronutrientes. 
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La ingesta diaria de los antioxidantes de cada participante se calculó a partir de 
todos los productos alimenticios, calculando su contenido de β-caroteno, 
vitamina A, vitamina E, vitamina C, selenio y zinc. Lo mismo se repitió para el 
cálculo de la ingesta de los  ácidos grasos poliinsaturados omega-3 y omega-6. 
La variable del consumo diario de pescado y marisco se calculó sumando 
cualquier tipo de pescado y otros mariscos tales como mejillones, crustáceos y 
pulpo. La ingesta de aceite se calculó a partir del consumo promedio de aceite 
de oliva o cualquier otro tipo de aceite vegetal, que se utilizaba para cocinar o 
para aliñar. 
El consumo de tabaco fue determinado según las normas de un cuestionario 
estándar elaborado por la Organización Mundial de Salud. 
Para el análisis de datos se utilizaron los paquetes estadísticos SPSS (Statistical 
Packagefor Social Sciences) versión 18.0 y STATA versión 12.0 (StataCorp LP, 
College Station, Texas). Se examinaron las distribuciones de las variables y en 
aquellas que no seguían una distribución normal se procedió a realizar una 
conversión logarítmica para aproximarse a la normalidad. El diseño del estudio 
nos permitió calcular los odds ratio (OR) y sus intervalos de confianza del 95% 
para cada factor de riesgo. El análisis consistió en un modelo multivariado de 
regresión logística condicional sobre los factores edad y sexo, ajustado por 
variables potencialmente confusoras. Se consideraron como variables de 
confusión o modificadoras de efecto todas aquellas que ejercieron efecto en el 
análisis univariante, modificando el efecto de la variable principal en más de un 
10%. Al final 5 variables de confusión principales fueron seleccionada para su 
inclusión en el modelo final: nivel de estudios, antecedentes personales de 
asma, antecedentes personales de dermatitis alérgica, antecedentes familiares 
de alergias e ingesta total de grasas. La ingesta total de kilocalorías también fue 
considerada en algunos modelos finales como variable potencial de confusión.  
La muestra definitiva de este estudio consistió de 774 sujetos, de los cuales 387 
eran casos de rinitis alérgica y 387 eran controles, pareados por edad y sexo. La 
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tasa de la respuesta global fue 72.5%. La edad media de los participantes fue 
34.5 años, con un rango de 18 a 77. La muestra consistió en 129 hombres (33%) y 
258 (67%) mujeres en en cada grupo. 
El dato más relevante de este trabajo es el hallazgo de que un alto consumo de 
proteínas aumenta el riesgo de la rinitis alérgica (OR = 3.79; IC del 95%: 2.40 a 
5.97 para el último cuartil de la ingesta). La asociación fue mayor después de 
ajustar por los factores de confusión (OR = 9.07; IC del 95%: 1.92 a 42.83 para el 
4o cuartil). La ingesta total de energía y la ingesta total de grasa también se 
asociaron con el consumo de proteínas. Sin embargo, al ajustar por estas 
variables el efecto del consumo de proteínas sobre el riesgo de la rinitis alérgica 
no se redujo, sino que se observó un incremento. Las proteínas de origen animal 
parecen ejercer mayor efecto que las proteínas de origen vegetal, aunque ambas 
mostraron un incremento en el efecto para el cuartil más alto después del ajuste 
por las variables confusoras. En el análisis de los aminoácidos por separado, el 
consumo elevado de leucina, tirosina, valina y serina se asocia con un aumento 
del riesgo y un efecto dosis-respuesta.  
Los resultados obtenidos para la mayoría de los aminoácidos analizados (ß-
caroteno, vitamina A, vitamina E, vitamina C, selenio y zinc) indican la 
existencia de una importante asociación entre estas variables y el desarrollo de 
la rinitis alérgica. La asociación positiva más fuerte se observó entre la ingesta 
alta de β-caroteno y rinitis alérgica, que aumento aún más después de ajustar 
por las variables de confusión (OR = 5.12; IC del 95%: 1.54-17.04 para 4o cuartil). 
El consumo alto de la vitamina A fue relacionado con un aumento en el riesgo 
sólo antes de ajustar por otras variables  (OR= 2.87; 95% CI: 1.82-4.52 para 4o 
cuartil). Las vitaminas E y C no han tenido efecto apreciable en el modelo 
ajustado, mientras que los minerales selenio y zinc mostraron efecto, limitado, 
sin embargo, para el 3er cuartil. El mayor consumo de frutas fue 
significativamente relacionado con el riesgo de la rinitis alérgica antes y 
después de ajustar por las variables de confusión (OR=3.12; 95% CI: 2.00-4.87 y 
OR=5.11; 95% CI: 1.67-15.63 para los últimos cuartiles, respectivamente). El 
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consumo de verduras se relacionó con la enfermedad sólo en el análisis crudo 
(OR=3.11; 95% CI: 1.95-4.96 para 4o cuartil), sin embargo, esta relación pierde 
significación  después de ajuste.  
Los valores altos de los ácidos grasos poliinsaturados en la dieta diaria 
mostraron tendencia a disminuir el riesgo de la rinitis alérgica para el último 
cuartil del consumo después de ajustar por otras variables de confusión, 
aunque la asociación no fue estadísticamente significativa (OR=0.42; 95% CI: 
0.13-1.38 para omega-3 y OR=0.55; 95% CI: 0.15-2.02 para omega-6). Puesto que 
las fuentes principales de los ácidos grasos omega-3 son pescado y marisco, y 
de los ácidos grasos omega-6 aceites vegetales, estas variables también fueron 
consideradas en el análisis. Sin embargo, Los resultados no cambiaron 
sustancialmente después de incluir el consumo de estos grupos de alimentos en 
el modelo. 
Como en cualquier estudio de casos y controles, el sesgo de la memoria es una 
de las debilidades de este estudio. También existe la posibilidad de medición 
errónea de los valores de macro y micronutrientes, pero es más probable que 
eso no sea diferencial respecto al estado de la enfermedad. Por otra parte, a 
pesar de las cifras relativamente altas de sensibilidad y especificidad de nuestro 
diagnóstico de la rinitis alérgica, la clasificación errónea de caso no se puede 
descartar, puesto que los síntomas de la rinitis se confunden a menudo con 
infecciones de las vías respiratorias superiores, como el catarro común o la 
sinusitis. 
Los resultados de ambas partes de este trabajo confirman que los factores 
ambientales modificables, tales como tabaquismo y alimentación, influyen en la 
aparición de rinitis alérgica. Se ha demostrado que había una asociación entre la 
exposición al humo del tabaco y la rinitis alérgica, esencialmente en niños.  
Por otra parte, la alimentación también parece sobre la aparición de rinitis. Los 
resultados de este estudio confirman que un consumo excesivo de proteínas y 
de algunos antioxidantes, tales como ß-caroteno, puede aumentar el riesgo de 
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rinitis alérgica. Al contrario, el consumo alto de ácidos grasos poliinsaturados 
omega-6 y omega-3 ejerce un efecto protector sobre la enfermedad. 

